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TRIBUTE
Millions and millions of children were vaccinated and monitored under 
sensitive surveillance through the efforts of thousands and thousands of 
national workers and with the assistance of hundreds of experts from around 
the world.
It was not only hard work but often dangerous work in some places. 
We would like to show our great appreciation and pay respect to those who
worked during Operation MECACAR and lost their lives in the process.
Operation MECACAR (the coordinated poliomyelitis eradication efforts in Mediterranean, Cau-
casus and central Asian republics) reaffirms that tremendous public health accomplishments 
are feasible when national governments, WHO, the United Nations Children’s Fund (UNICEF), 
and other external partners work together closely – in this case, with the primary goal of reach-
ing every child with oral polio vaccine. Since 1995, 18 countries and areas with diverse political 
systems have met regularly to exchange information openly, and to plan sound strategies to fight 
infectious diseases together. 
The success of Operation MECACAR is clear. Participants synchronized national immunization 
days (NIDs) against poliomyelitis so that children in mobile population groups could be immu-
nized simultaneously. As a consequence, 15 of the participating countries and areas reported no 
indigenous poliomyelitis cases in 2000, with steep reductions in the number of cases in the oth-
ers. In addition to the impact on poliomyelitis incidence, participants benefited from improved 
dialogue, the sharing of lessons learned, and joint planning.
Operation MECACAR has directly influenced the approach to poliomyelitis eradication world-
wide. In western and central Africa, 17 countries have already synchronized their NIDs in the 
autumn of 2000. These countries used the lessons of Operation MECACAR and decided to unite 
in an effort to rid their children forever of the threat of poliomyelitis. This collaboration will un-
doubtedly lead to increased collaboration on other health goals. 
The mechanism of Operation MECACAR could be adapted for use in other areas of the world, as 
we seek to certify poliomyelitis eradication in 2005. All countries and areas must work together to 
exchange information, maintain certification-standard surveillance and contain laboratory po-
liovirus stocks. In addition, the MECACAR process provides a forum to coordinate policy for 
stopping poliomyelitis immunization.
As we strive for health equity in the twenty-first century, we should take to heart the lessons of 
Operation MECACAR. Diverse partners can unite to achieve seemingly insurmountable health 
goals. By using sound technical strategies and working together, we can stop infectious diseases 
in their tracks. Not only infectious diseases but also risk factors such as environmental pollution 
and tobacco use cross national borders to harm health. Operation MECACAR provides a valuable 
process by which to approach other health concerns. Obviously, not all problems can be tackled 
simultaneously. Setting priorities, while pursuing measurable and achievable objectives, is the key 
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to monitoring and evaluating progress towards improving the health of our children and our 
communities. 
Participants in Operation MECACAR are to be commended for their transparent and successful 
efforts, which have created a forum for partnership. Organizers of Operation MECACAR are to 
be commended for their vision, which has united health authorities and peoples around a com-
mon priority – ensuring that the health of our children improves. Let us continue to use and build 
upon the fine example provided by Operation MECACAR.
Dr G  H  B
WHO Director-General 
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The importance of Operation MECACAR cannot be stressed enough.
The organisms causing infectious diseases that are easily transmitted by respiratory and faecal-
oral routes, such as poliomyelitis, are not confined by national boundaries; neither do they affect 
only limited sections of the populations at risk.
Yet public health, including the control of infectious diseases and epidemics, has usually been 
managed on a national scale, each country developing its own capacity to react to infections and 
to reach and protect those communities at risk. This is also true of a country’s response to inter-
national initiatives, such as those developed to eradicate poliomyelitis by the year 2000. Within 
each country, responsibility for public health has predominantly rested only with the ministry of 
health, too often beset with problems of limited financial and personnel resources.
Operation MECACAR has demonstrated that these limitations – too circumscribed a response 
to a disease affecting people across all borders; inadequate, often undefined national resources 
to tackle the problem – can be overcome. Its success demanded and received clear technical and 
management leadership, well defined objectives, sound technical policies, but especially strong 
partnership and transparent communication, both within countries but also between countries 
and with international support agencies.
For more than 5 years, 18 countries and areas harmoniously worked together, sharing experi-
ences, collectively making more and more rapid progress than they would have done separately. 
All participants conducted national immunization days, synchronized with their neighbours. 
These were conducted each year, effectively protecting their own populations by together tackling 
infectious disease at its source, even if this was outside their own national boundaries.
The success of Operation MECACAR was based on effective coordination meetings, held annu-
ally, but with discussions extended to subregional and cross-border meetings. One of the most 
striking features of these meetings was the consistent participation of those officials most imme-
diately involved and responsible for the programme, so that experiences were shared, discussions 
held and solutions were reviewed to ensure relevance, practicality and operational feasibility. 
The results of Operation MECACAR have been excellent. Fifteen MECACAR countries and ar-
eas, including all those in the WHO European Region have apparently stopped indigenous wild 
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poliovirus transmission by 2000. In the other three MECACAR countries, incidence is greatly 
reduced, even in Afghanistan, where it might have been reasonable to expect that civil conflict 
would have prevented an effective programme of immunization. Even the fighting was stopped 
for the NIDs!
Surveillance has been much developed and data are freely exchanged. A network of accredited 
laboratories provides reliable diagnostic support and allows individual strains of virus to be 
traced whenever cases occur.
It can now be said, with confidence, that all portions of all the 18 participating countries and areas 
and all populations within them have been reached and included in effective activities needed to 
eradicate poliomyelitis. Within countries, all elements of society – national leaders, religious heads, 
leading community figures, stars of the media and the sporting world – have participated in this 
health initiative. In addition to the armies of health workers, the staff of many other ministries, 
women’s and children’s groups and nongovernmental organizations have been fully involved.
Infectious diseases will continue. They will infect populations across borders. They will prob-
Dr H  A. G
WHO Regional Director for 
the Eastern Mediterranean
Dr M  D
WHO Regional Director
for Europe
ably, on occasion, be too extensive 
for health staff alone to tackle ef-
fectively. Operation MECACAR has 
clearly demonstrated that it is possi-
ble to tackle epidemics and deficien-
cies in health support with a truly 
cooperative, international initiative. 
The international agencies, the coun-
tries themselves and their agencies, 
communities and residents surely 
want this and have demonstrated 
that they can all play a critical part-
nership role in achieving it.
We cannot afford to ignore the 
lessons learned through Operation 
MECACAR.
xiF O R E W O R D  B Y  T H E  W H O  R E G I O N A L  D I R E C T O R S






In the 1950s and 1960s, the development of effective vaccines against poliomyelitis (or polio) al-
lowed many countries to control the disease and to eliminate the risk of widespread epidemics. 
Most countries introduced the vaccines as a part of their routine schedule for infant immuniza-
tion, but a small number, notably Czechoslovakia and Cuba, demonstrated that administering 
oral polio vaccine (OPV) in mass campaigns resulted in the rapid and complete disappearance of 
clinical poliomyelitis.
In 1984, the Directing Council committed the Pan American Health Organization to the eradica-
tion of poliomyelitis from the western hemisphere by 1990. Effective strategies, including the use 
of national immunization days (NIDs), were developed and facilitated rapid progress towards 
this goal. Based on evidence of this progress, and in view of the outstanding development of na-
tional immunization programmes under the Expanded Programme on Immunization (EPI), the 
Forty-fourth World Health Assembly, meeting in 1988, established a target for the global eradica-
tion of poliomyelitis by the year 2000.
REGIONAL POLIOMYELITIS ELIMINATION
The countries and areas subsequently involved in Operation MECACAR form part of two sepa-
rate regions of WHO: the European and the Eastern Mediterranean. Member States of both re-
gions are committed to poliomyelitis eradication, as reflected in their regional committee resolu-
tions on this subject.
Operation MECACAR involved close coordination between the two regions, with common strat-
egies and similar monitoring of progress in all areas involved. It was, therefore, a single and uni-
fied campaign, involving all countries and areas equally. In reviewing background factors and 
progress within limited geographical areas, however, it is practical and simpler to analyse each 
region separately. The countries and areas involved in Operation MECACAR and their relation-




In 1985, the WHO Regional Committee for Europe established the reduction of communicable 
disease as its fifth regional target. This target specified that:
By the year 2000, there should be no indigenous cases of poliomyelitis, diphtheria, neonatal 
tetanus, measles, mumps and congenital rubella in the Region and that there should be 
a sustained and continuing reduction in the incidence and adverse consequences of other 
communicable diseases, notably HIV infection.
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Figure 1.
Countries and areas 
of the WHO Eastern 
Mediterranean and 
European regions 



























The designations employed and the pres-
entation of this material do not imply the 
expression of any opinion whatsoever on 
the part of the Secretariat of the World 
Health Organization concerning the legal 
status of any country, territory, city or area 
or of its authorities, or concerning the de-
limitation of its frontiers or boundaries.
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In 1989, this target was confirmed by the thirty-ninth session of the Regional Committee, which 
specifically endorsed the target of regional poliomyelitis elimination by 2000 and approved the 
plan of action aimed at its achievement.
By 1994, a full course of polio vaccine, administered as routine immunization in the first year of 
life, was being received by 82–83% of children in the Region. The number of countries reporting 
over 80% coverage had, however, declined from 31 in 1991 to 26 in 1994 of 51 Member States. 
It was also recognized that, even within countries with high levels of routine immunization, cer-
tain areas were recording coverage markedly lower than 
national averages. The break-up of the former USSR had 
led to temporary vaccine shortages in several countries, 
with consequently reduced immunization coverage.
Although surveillance for poliomyelitis was unsatisfac-
tory, endemic poliovirus transmission was still thought 
to be occurring in 11 countries across a wide area from 
Turkey to Tajikistan, with frequent major epidemics af-
fecting countries in which numbers of children suscepti-
ble to poliomyelitis had accumulated. It was this situation 
that led to the germination of the concept for coordinated 
action, a concept that developed to include two WHO re-
gions and became “Operation MECACAR”. This concept 
was developed further by the Regional Office for Europe 
along with, and supported by, WHO headquarters polio 
eradication staff, the coalition of international partners 
and the Regional Office for the Eastern Mediterranean.
Eastern Mediterranean Region
The thirty-fifth session of the Regional Committee for the 
Eastern Mediterranean, meeting in 1988, adopted a reso-
lution committing Member States to aim for poliomyeli-
tis elimination by the year 2000. A regional plan of action 
for poliomyelitis eradication was adopted in 1989.
In 1993 and in subsequent years, the Regional Commit-
tee reviewed progress and issued resolutions urging the 
22 Member States to fully implement strategies required 
for poliomyelitis eradication.
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In the Eastern Mediterranean Region, during the decade leading up to Operation MECACAR, the 
development of increasingly effective national immunization programmes had produced dra-
matic improvements in rates of childhood immunization, for example immunization coverage 
with the third dose of oral polio vaccine by 1 year of age (OPV3 coverage) had increased from 
30% in 1984 to over 80% in 1993 in the Region overall. By 1994, most countries and areas in the 
Region had developed and been able to sustain effective childhood immunization services, while 
NIDs had been successfully conducted in some countries of the Region.
Yet, for widely differing reasons, three countries that later committed to Operation MECACAR 
were facing considerable difficulties in 1994. Continuing civil conflict in Afghanistan had pre-
vented the establishment of effective nationwide immunization and surveillance systems. In Iraq, 
the Gulf War and its consequences had severely affected a previously effective immunization pro-
gramme. In Pakistan, major difficulties had been encountered in sustaining achievements beyond 
1990; in fact, immunization coverage declined to reach its lowest level in 1995, before improving 
in 1996. 
While surveillance for poliomyelitis became increasingly effective, sub-national reporting was 
still far from complete and poliomyelitis remained much underreported. By 1994, although the 
number of cases continued to decline, reflecting high routine and NID immunization achieve-
ments, poliomyelitis was still reported in most countries and areas of the Region, and was of es-
pecially high incidence and widespread within the eastern countries of Pakistan and Afghanistan 




In the Eastern Mediterranean Region, by 1994, effective routine immunization programmes and 
mass immunization campaigns had controlled the incidence of poliomyelitis in three countries 
and areas adjacent to countries of the European Region – the Syrian Arab Republic (reduced to 
a very low incidence), Iraq and the Islamic Republic of Iran – and also in Lebanon and in the 
Palestinian Self-Rule Areas. Before and following energetic control of an epidemic mainly affect-
ing migrant workers of Pakistan origin in 1992 and with high routine immunization coverage for 
several years plus supplementary immunization, Jordan had apparently interrupted poliovirus 
transmission.
Poliomyelitis was still widespread in Pakistan in 1994, although the number of reported cases 
had been reduced by a mass immunization campaign. There was also an assumed high incidence 
in Afghanistan, where the health infrastructure had been disrupted for many years and disease 
control activities were not able to operate effectively throughout the entire country. Neighbour-
ing countries were experiencing repeated importation of poliomyelitis from this transmission 
pool. As noted above, the 1991 Gulf War in Iraq had caused a breakdown in its previously effective 
routine immunization programme of infants, with a consequent marked increase in the number 
of poliomyelitis cases reported and continuing transmission in the years up to 1994.
European Region
Following the first introduction of polio vaccines in the 1950s and 1960s, a low incidence of polio-
myelitis had been reported throughout the European Region for many years, with most countries of 
western, northern and central Europe having reported zero cases since the mid-1980s or earlier. 
After years of declining incidence between 1990 and 1994, the annual number of reported 
cases had subsequently remained at around 200 or more each year. This total figure com-
prised two components:  persisting endemic transmission in a small number of countries, 
most notably Turkey, and the occurrence of major epidemics in countries previously re-
porting few, if any, cases in the preceding years. Such epidemics had occurred in Tajikistan 
(115 cases in 1991), Azerbaijan (182 cases in 1990; 69 in 1993) and Uzbekistan (117 cases 
in 1994). In each case, the epidemic was tackled vigorously and the number of reported 
cases fell dramatically, only for another epidemic to occur elsewhere. 
In 1993 and 1994, 11 countries of the European Region had reported poliomyelitis cases 
to WHO and/or were still considered to be polio-endemic. In addition to those countries 
which would ultimately join Operation MECACAR, Ukraine and the Federal Republic of 
Yugoslavia had cases of virologically confirmed poliomyelitis before 1994 and continued 
to report cases of poliomyelitis in 1994 (without laboratory confirmation). At that time, 
with relatively few cases being reported and most countries of western, northern and cen-
tral Europe reporting high routine immunization coverage of infants, the disease was not widely 
perceived as a major public health risk to the regional population as a whole. Yet, based on the 
strategies being implemented at that time and with the wide distribution of cases, it appeared 
probable that low-level wild poliovirus transmission would persist indefinitely, with occasional 
major epidemics. With those strategies alone, it was therefore unlikely that the target of poliomy-
elitis elimination from the European Region would be achieved by the year 2000.
In both regions, it was clear that well-coordinated, synchronized mass immunization campaigns 
by neighbouring countries and areas that were either polio-endemic or at high risk of importa-
tions would have great effect; such campaigns would not only reduce the number of cases but 
would also confine poliovirus transmission to a more limited geographical area and be a major 
step towards accelerating poliovirus elimination.
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Based on the 
strategies being 
implemented in 
1994, it was 
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2000.
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to remote areas, 
Afghanistan 1995
(far right).
An equally important aspect was that, without such an innovative approach, it appeared probable 
that in many countries existing policies would not be sufficient to secure the targets of regional 
poliomyelitis eradication and global eradication by the year 2000.
POLIOVIRUS CIRCULATION
At the time that Operation MECACAR was planned, limited information was available on the 
circulation of different strains of polioviruses within the target area. The information available 
and that which became available later did in fact strongly justify the decision to implement mass 
immunization coordinated between countries and regions.
When OPV was first introduced on a massive scale to the countries of the European Region, the 
circulation of wild poliovirus was widely curtailed, apparently leading to rapid virus elimination 
in most western countries. There is now evidence to suggest that elimination of Types 1 and 2 wild 
poliovirus occurred in the countries of eastern Europe, including most of the former Soviet Union. 
In the early 1990s, three families (genotypes) of Type 1 poliovirus had been isolated from cases 
in MECACAR countries of the European Region. Their range of genetic variability suggests that 
all three genotypes originated from relatively recent introductions. Genomic sequencing of viral 
RNA segments has demonstrated a close relationship with polioviruses currently or recently cir-
culating in the Middle East and in Pakistan/India. 
Epidemics in 1991 in Tajikistan, in 1992 in Ukraine, in 1994 in Uzbekistan and in 1995 in Chech-
nya of the Russian Federation, were all caused by a closely related Type 1 virus, the “T” (Tajikistan) 
virus. A similar virus has been isolated in more recent years in Pakistan and similar isolates, prob-
ably from importations, had been isolated in Jordan and Malaysia. A different Type 1 virus, the “A” 
(Azerbaijan) virus was isolated from Azerbaijan and Georgia in 1991, the Islamic Republic of Iran 
in 1993 and Iraq in 1994. This virus is related to older middle eastern strains. A third genotype 
Type 1 virus, the “G” (Georgia) virus was isolated from Georgia in 1991 and the Russian Federa-
tion in 1994. This virus is closely related to the “A” virus.
As the poliomyelitis eradication initiative has developed, genetic sequencing has repeatedly dem-
onstrated the ease with which polioviruses cross international borders, for example with similar 
viruses being identified, often in different years, in Iraq and Turkey, in the Islamic Republic of 
Iran and Tajikistan, and in Afghanistan and Pakistan. 
By contrast, isolates of Type 3 viruses in the European Region fall into four distinct groups, show-
ing a much wider variability, strongly suggesting continuing transmission within the countries of 
the Region for many years. These are unlikely to have been the result of recent importations.
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Newer information on the genetic sequencing of more recent virus isolations from Afghanistan, 
Pakistan and India have indicated that there are distinct shared reservoirs of virus in Afghanistan 
and Pakistan and separate genotypes circulating in India. Nonetheless, there also have been dif-
ferent circulating genotypes identified in Afghanistan and in Pakistan. 
These findings indicate that wild polioviruses have circulated among the very different countries 
and areas of both the European and Eastern Mediterranean Regions with ease and lack of restric-
tion. It is clear that elimination of poliomyelitis in the geographical area covered by MECACAR 
necessitated a programme capable of achieving synchronized high immunization coverage and 
effective surveillance across borders and between regions. Operation MECACAR fulfilled that 
requirement. 
INITIATING OPERATION MECACAR
The theme of World Health Day on 7 April 1995 “Target 2000 – A World Without Polio” acted as 
a stimulus to develop effective national and international programmes aimed at meeting the po-
liomyelitis eradication target. The idea to conduct coordinated NIDs in endemic countries with 
common borders was already developing in the Regional Office for Europe. With the upcoming 
1995 World Health Day, Operation MECACAR was developed as a larger process for two regions 
and supported by the major partners. 
In conjunction with that World Health Day, 18 geographically contiguous countries and areas 
in Europe, central and southern Asia and in the Middle East committed themselves to conduct-
ing coordinated and synchronized NIDs using OPV. The programme was designated as Opera-
tion MECACAR (MEditerranean, CAucasus and Central Asian Republics). These areas related to 
eight countries and areas of the Eastern Mediterranean Region and ten countries of the European 
Region of WHO. Throughout the years of Operation MECACAR, participating countries and 
areas of the Eastern Mediterranean Region remained the same, while in the European Region the 
Russian Federation replaced Bulgaria in 1996 after the first NIDs in 1995. A number of additional 
countries affected by epidemics of poliomyelitis – Albania, the Federal Republic of Yugoslavia 
and Greece – and other countries seeking to boost their population immunity conducted sup-
plementary immunization campaigns often in conjunction with Operation MECACAR, but not 
as an integral part of the initiative.
In 1994, the participating countries and areas of the Eastern Mediterranean Region, the Islamic 
Republic of Iran, Iraq, Jordan, Lebanon, Pakistan and the Syrian Arab Republic, had reported 
691 (69%) of the regional total of 1015 reported cases for the same year. The participating Euro-
pean Region countries, Armenia, Azerbaijan, Kazakhstan, Tajikistan, Turkey, Turkmenistan and 
Uzbekistan, had reported 206 (89%) of the regional total of 231 polio cases. 
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Based on experience that conducting NIDs in the low season of poliovirus transmission markedly 
increased their effectiveness, the representatives of all participating countries and areas meeting 
in Ankara, Turkey in January 1995 agreed to schedule either the first or the second round of their 
campaigns in April around World Health Day, 7 April 1995, dedicated to poliomyelitis eradica-
tion.
Critically, at this first coordination meeting, representatives of the MECACAR Member 
States committed participating countries and areas to conducting further synchronized 
NIDs in 1996 and 1997, to the introduction of “mopping-up” strategies of focal supple-
mentary immunization activities where indicated by surveillance data, developing na-
tional surveillance for acute flaccid paralysis (AFP) and maintaining high routine immu-
nization coverage. These critical resolutions changed the nature of Operation MECACAR 
from being a one-time mass campaign to becoming a structured, coordinated and tech-
nically sound programme aimed at the early achievement of poliomyelitis elimination 
throughout the target area. It was also agreed that Operation MECACAR should be time 
limited, terminating in its proposed form after three years. Discussion at subsequent co-
ordination meetings would later propose extension as “Operation MECACAR Plus”.
The first coordination meeting also stressed the need for the NIDs to be of uniform high 
quality. This requirement necessitated and led to sound planning, the involvement of na-
tional leaders at the highest level and appropriate leaders at each successive administrative 
and community level, the effective use of the media and the coordinated involvement of 
all relevant sectors in government. In addition, nongovernmental organizations (NGOs) 
and all national and international agencies with an interest in assisting health development in 
participating countries and areas were integrally involved.
In implementing Operation MECACAR, it was seen to be important that the planning, ap-
proaches and activities should be compatible with the different organizational structures and 
cultural requirements of the widely differing communities living within such a vast geographical 
area. That this was realized without serious dispute testifies to the significant achievement of the 
planning by responsible national and international officials.
Four closely interrelated elements constituted Operation MECACAR, each being important if the 
primary and secondary objectives of the initiative were to be realized:
• strengthening of the partnership aimed at achieving poliomyelitis eradication in the   
European and Eastern Mediterranean Regions, between and within all countries and areas;
• conducting coordination meetings, in which planning was developed, progress reviewed and 
problems identified, technical issues discussed, resource needs identified and solutions sought;
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• planning and conducting of coordinated and synchronized NIDs; and
• further developing effective, broadly based programmes, utilizing WHO-recommended 
strategies which would result in and confirm the final eradication of poliomyelitis. These 
programmes should essentially include the development of effective virological surveillance 
for all cases of childhood AFP.
CONFLICT SITUATIONS 
The area covered by Operation MECACAR includes a number of countries and areas where in-
ternal disturbances or armed conflicts have taken place during the last decade.  This includes civil 
wars in major areas of Afghanistan and Tajikistan; armed conflicts or internal disturbances in Az-
erbaijan, Georgia, Iraq, and some territories of the Russian Federation in the northern Caucasus; 
and tensions along the borders of Iraq, the Islamic Republic of Iran, the Syrian Arab Republic and 
Turkey.  
Such disputes, whatever their justifications, often made it difficult or even impossible to imple-
ment carefully planned public health programmes such as for immunization. The progress of 
Operation MECACAR and its potential for effective planning of activities was repeatedly threat-
ened by such conflicts. Contingency plans were developed and appropriate activities, such as 
“days (or weeks) of tranquillity”, were proposed to enable procedures for effective immunization 
to take place. Such breaks in fighting were implemented in Afghanistan during campaigns from 
1994 onwards and in Tajikistan during the 1995 NIDs.  
It is to the credit of all those involved that these conflicts did not seriously delay the overall out-
come of Operation MECACAR, except in Afghanistan. Indeed, resolution of the difficulties faced 
by delivering immunization services often offered hope of the eventual wider resolution of the 
conflicts. 
BORDER AREAS
Even if  armed conflict is avoided, tensions have often affected efficient delivery of health services 
in border or other population subgroups. During 1997–1998, prevention of cross-border trans-
mission and distant importation of wild poliovirus received special attention. Coordinated bor-
der activities between neighbouring countries and areas of the Eastern Mediterranean and Euro-
pean Regions were organized. Special immunization and surveillance activities were introduced 
in selected border areas of the Islamic Republic of Iran, Iraq, the Syrian Arab Republic and Turkey 
during October-November 1997 to 2000. Similar considerations were made for the border areas 
of Afghanistan, the Islamic Republic of Iran and Pakistan, and to a lesser extent, border areas of 
Tajikistan, Turkmenistan and Uzbekistan with Afghanistan.
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type 1 polio in 
Sirnak province, 
Turkey 1998
Because of the vast geographical area covered, the fact that two WHO regions were involved and 
the need for the active participation of 18 countries and areas, MECACAR was a complex techni-
cal operation. Its successful management necessitated close and frequent communication and ef-
fective coordination between partner agencies and with the ministries involved in all participat-
ing countries and areas. 
It was important that all areas and agencies agreed and accepted the objectives towards which Op-
eration MECACAR was targeted. This was achieved without serious disagreement and without 
any disruption of planned activities, reflecting the outstanding commitment of all governments 
and agencies concerned.
PRIMARY OBJECTIVES
The primary objective of Operation MECACAR was to provide a mechanism to institute and 
coordinate activities, predominantly NIDs, that would rapidly lead to poliomyelitis elimination 
throughout all participating countries and areas. 
Inherent within this primary objective was the potential for technical development within coun-
tries and areas, leading to the further implementation of effective health-promoting activities. 
It was also expected that a stronger partnership could be developed among the various agencies 
involved and between the two WHO regions.
Successfully conducted NIDs, coordinated among countries and areas, had the realistic potential 
to create extensive polio-free areas which, in turn, would reduce the possibility of importations 
to individual countries and which would prove to be a major contribution to eventual regional 
elimination and global poliomyelitis eradication.
OBJECTIVES OF
OPERATION MECACAR
14 O P E R AT I O N  M E C A C A R :  F I N A L  R E P O R T
SECONDARY OBJECTIVES
A number of secondary objectives were also defined at the onset, while others became evident and 
potentially achievable as Operation MECACAR progressed. These included the following:
 Technical implementation
• development and monitoring of AFP surveillance in participating countries and areas;
• development and use of a WHO-accredited laboratory network, with improved coordination 
between epidemiological and laboratory staff; and
• advancement of reporting systems, information analysis and feedback, including sharing of 
epidemiological information between Member States and with international agencies.
General coordination
• promotion of partnership between and among Member States and agencies, with increased 
awareness of the needs, potential for availability of funds and effective use of resources; 
• production of data for eventual certification of poliomyelitis eradication; and
• promotion of a capacity for international cooperation in the future control of communicable 
diseases.
Although the principles of Operation MECACAR were devised by international staff working 
in the WHO regional offices in close association with their colleagues in UNICEF, Rotary Inter-
national PolioPlus and the Centers for Disease Control and Prevention (CDC), it was through 
the conduct of the coordination meetings and the contribution of the participants that its true 
potential was developed. 
Each meeting played a vital role as a forum for allowing technical discussion, defining logistical 
needs, ensuring effective planning and further developing coordination.
The meetings were attended by representatives of the participating countries and areas, usually 
senior officials from ministries of health and, always, national immunization programme manag-
ers. WHO and UNICEF advisers from regional offices, headquarters and staff based in participat-
ing countries and areas provided the secretariat. Other organizations were strongly represented, 
notably Rotary International, the CDC, Basic Support for Institutionalizing Child Survival (BA-
SICS), the US Agency for International Development (USAID), the International Federation of 
Red Cross and Red Crescent Societies (IFRC) and the International Medical Corps (IMC).
In addition, observers from the host country attended each meeting, while representatives of the 
regional commissions for the certification of poliomyelitis eradication and scientists from labo-
ratories within the WHO network participated in a number of meetings.
In total, six coordination meetings were held. Their agendas modified as time passed, moving 
from an initial emphasis on planning to greater stress on review of progress, evaluation and iden-
tification of areas of weakness, the development and monitoring of AFP surveillance and im-
proved use of the laboratory network.
OPERATION MECACAR
COORDINATION MEETINGS
By the end of each meeting, progress had been reviewed, technical and logistic requirements dis-
cussed, and conclusions and recommendations developed. Reports of meetings, with the recom-
mendations, were circulated to all participating authorities. 
While these Operation MECACAR coordination meetings concentrated on technical planning 
and identification of needs, especially for the implementation of NIDs, further agency meetings 
were conducted as interagency coordination committees at the regional and national levels, coor-
dinating ideas and financial resources and seeking commitments to meet needs. These two types 
of meetings were complementary and each type provided major support to national activities.
In view of the critical role of the Operation MECACAR coordination meetings, and as a record of 
the development of strategies and monitoring of progress, each is summarized below. 
FIRST COORDINATION MEETING OF OPERATION MECACAR
Ankara, Turkey, 29–30 January 1995.
Participants
WHO Eastern Mediterranean Region: Afghanistan, Islamic Republic of Iran, Iraq, Jordan, 
Lebanon, Pakistan, Syrian Arab Republic. 
WHO European Region: Azerbaijan, Georgia, Kazakhstan, Kyrgyzstan, Tajikistan, Turkey, 
Turkmenistan, Uzbekistan. 
Partner organizations: BASICS, CDC, IFRC, Rotary International PolioPlus, UNICEF, USAID, 
WHO.
Context of the first meeting
Pakistan had reported over 1800 cases in 1993, but the reported incidence had been dramatically 
reduced to 527 in 1994 following NIDs. Similarly, the Islamic Republic of Iran, like most countries 
of the Eastern Mediterranean Region, had conducted a highly effective NID with conspicuously 
successful intersectoral cooperation, while Afghanistan had conducted its first multiantigen mass 
campaign. In Tajikistan, a major epidemic in 1991 had been controlled, although cases were still 
occurring, with 26 in 1994. Azerbaijan had reported 69 cases in 1993, reduced to only 16 in 1994. 
Conversely, Uzbekistan had reported 68 cases in 1993 and 117 in 1994. 
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Main findings
• most participating countries and areas had achieved 80% immunization coverage, but in 
some, civil  unrest or uncertain vaccine supplies had resulted in declining achievement;
• in 1994, the Islamic Republic of Iran, Lebanon, Pakistan, the Syrian Arab Republic and  
Uzbekistan had successfully conducted NIDs;
• surveillance was established, but required substantial strengthening; and
• countries and areas participating in Operation MECACAR were committed to conducting 
NIDs  during March-May 1995.
Key recommendations
• there must be commitment to NIDs in 1995, 1996 and 1997;
• one round of NIDs to be coordinated on/around 7 April 1995;
• countries to seek strong commitment to NIDs at the highest level;
• special efforts to be made to reach migrant and other hard-to-reach populations;
• all sectors of government and community to be involved in the NIDs;
• particular use of social mobilization and effective use of the media; and 
• prompt reporting of results within one month after the second round. 
SECOND COORDINATION MEETING OF OPERATION MECACAR
Tehran, Islamic Republic of Iran, 27–28 September 1995.
Participants
WHO Eastern Mediterranean Region: Afghanistan, Islamic Republic of Iran, Iraq, Jordan, 
Lebanon, Palestinian Authority, Syrian Arab Republic. 
WHO European Region: Armenia, Azerbaijan, Georgia, Kazakhstan, Kyrgyzstan, Tajikistan, 
Turkey, Turkmenistan, Uzbekistan. 
Partner organizations: Rotary International PolioPlus, UNICEF, WHO.
Context of the second meeting
The first NIDs were followed by a dramatic reduction in poliomyelitis in most of the participat-
ing countries. Only Turkey and Pakistan were reporting significant numbers of endemic cases, al-
though Afghanistan was unable to document incidence accurately. Chechnya in the Russian Fed-
eration, after a period of virtually absent routine infant immunization services (with consequent 
extremely low polio vaccine coverage), was suffering a major epidemic of poliomyelitis, with 150 
cases ultimately reported in 1995.
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Main findings
National immunization days:
• the first round of Operation MECACAR involved 18 countries and areas and was implemented 
successfully in March–May with all participating countries and areas achieving high coverage 
(more than 90%); and
• additional resources had been mobilized at the national level.
Incidence of poliomyelitis:
• in 1994, in the Eastern Mediterranean Region, 11 countries and areas reported indigenous 
polio cases, although Somalia and Afghanistan were unable to report. Reported cases in 
MECACAR countries and areas of the Region decreased from 1985 cases in 1993 to 691 in 
1994;
• in the European Region, 11 countries reported indigenous cases with 74 geopolitical units 
reporting cases, compared with 105 in 1992.
Surveillance for cases of acute flaccid paralysis:
• in the Eastern Mediterranean Region in 1994 with an overall non-polio AFP rate of 0.49, 74% 
of cases were submitted to virological investigation; 
• completeness of monthly reporting to the European Region was 90-96%, with the reported 
non-polio AFP rate varying from 0.3 to 0.8 per 100 000 children in the MECACAR countries. 
Key recommendations  
• continuation of  NIDs in 1996 and 1997 and countries and areas with significant cross-border 
migrations to conduct well-synchronized NIDs; 
• focus on developing efficient surveillance; and
• consideration of the need for mopping-up operations in high-risk areas.
THIRD COORDINATION MEETING OF OPERATION MECACAR
Tashkent, Uzbekistan, 14–16 October 1996.
Participants
WHO Eastern Mediterranean Region: Afghanistan, Islamic Republic of Iran, Iraq, Jordan, Leba-
non, Pakistan, Palestinian Authority, Syrian Arab Republic. 
WHO European Region: Armenia, Azerbaijan, Georgia, Kazakhstan, Kyrgyzstan, Russian Federa-
tion, Tajikistan, Turkey, Turkmenistan, Uzbekistan. 
Partner organizations: BASICS, CDC, IFRC, Rotary International PolioPlus, UNICEF and WHO.
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room during NIDs, 
Uzbekistan 1994
Context of the third meeting
The success in the MECACAR participating areas was evident, with a greatly reduced incidence 
of poliomyelitis. To the west of the MECACAR area, however, a major epidemic occurred, with 
ultimately 138 cases reported from Albania in 1996, 24 from the Federal Republic of Yugoslavia 
(reported from Kosovo, an area with substantial civil unrest), and 5 cases from Greece. Mass im-
munization outbreak response activities rapidly gained control. In Turkey, areas known previ-
ously to have had low routine immunization coverage were still reporting polio cases, while en-
demic poliomyelitis remained widespread in Pakistan and Afghanistan, with cases in border areas 
of the Islamic Republic of Iran.
Main findings
National immunization days:
• in 1996, all MECACAR countries and areas in both regions joined by the Russian Federation 
participated in synchronized NIDs;  in 1996, outside MECACAR, Albania, the Republic of 
Moldova and Ukraine also conducted NIDs, and the Federal Republic of Yugoslavia conducted 
sub-NIDs.
Incidence of poliomyelitis:
• in the Eastern Mediterranean Region, 647 cases were reported by MECACAR countries and 
areas in 1995;
• in 1995, 206 cases of polio were reported in the European Region, 150 being from the Russian 
Federation, almost exclusively from Chechnya; and
• in 1996, an epidemic of ultimately 138 cases occurred in Albania and also involved subgroups 
in the Federal Republic of Yugoslavia and Greece.
Surveillance for cases of acute flaccid paralysis:
• in the Eastern Mediterranean Region, the overall reported non-polio AFP rate increased from 
0.49 in 1994 to 0.70 in 1995 and 0.71 in 1996;
• in 1995, surveillance data in the European Region were reported for 19 countries; and
• overall non-polio AFP rate per 100 000 children in the European Region was 0.24 in 1995, 
increasing to 0.53 in 1996. 
Key recommendations
• a commitment of all countries and areas to continuing NIDs in 1997 conducted in synchrony, 
with the exception of Pakistan, which coordinated the timing of NIDs with India  because of 
differing seasonal occurrence;
• highest 1997 priority to strengthen AFP surveillance, including meeting key performance 
indicators; and
• mopping-up in 1997 to be guided by the results of AFP and virological surveillance.
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FOURTH COORDINATION MEETING OF OPERATION MECACAR
Rome, Italy, 20–22 October 1997.
Participants
WHO Eastern Mediterranean Region:  Afghanistan, Islamic Republic of Iran, Iraq, Jordan, 
Lebanon, Pakistan, Palestinian Authority, Syrian Arab Republic. 
WHO European Region: Armenia, Azerbaijan, Georgia, Kazakhstan, Kyrgyzstan, Russian 
Federation, Tajikistan, Turkey, Turkmenistan, Uzbekistan; outside MECACAR: Albania, Bosnia 
and Herzegovina, Bulgaria, Greece, Italy, Republic of Moldova, the former Yugoslav Republic of 
Macedonia, Ukraine, the Federal Republic of Yugoslavia. 
Partner organizations: BASICS, CDC, IMC, Rotary International PolioPlus, UNICEF, USAID, 
WHO.
Context of the fourth meeting
In the European Region, there was promise of interruption of wild poliovirus circulation when no 
case had yet been reported for 1997 at the time of the meeting – later found to be an unmet prom-
ise. Concerns remained about continuing silent indigenous transmission in areas of the countries 
affected by the epidemic in 1996. Improvements in surveillance in both regions were made, but 
were limited. Mopping-up activities had been undertaken or planned in the countries and areas 
of both regions at highest risk of ongoing or cross-border transmission of wild polivirus.
Main findings
National immunization days:
• in 1995, in MECACAR countries and areas, 55 million children received two doses of OPV, 
with coverage of 95% of target being achieved;  in 1996, 60 million children received two doses, 
with coverage still at 95% of target; and
• in 1997, in the Eastern Mediterranean Region, 44 million children received OPV (including 
the first NIDs in Afghanistan)with coverage generally over 95%. In the European Region, 17 
million children were immunized, resulting in 95% coverage. 
Incidence of poliomyelitis:
• in MECACAR countries and areas of the Eastern Mediterranean Region, 377 polio cases were 
reported in 1996, a 42% reduction from 1995; and
• in 1996, 192 cases of polio were reported from European countries, 23 in MECACAR 
countries, affecting 45 geopolitical divisions.
Surveillance for cases of acute flaccid paralysis:
• in the Eastern Mediterranean Region, reported non-polio AFP detection rates were over 1.0 in 
five MECACAR countries and areas in 1997 and with adequate samples from over 50% of cases 
in all countries and areas except Afghanistan and Pakistan; 
22 O P E R AT I O N  M E C A C A R :  F I N A L  R E P O R T
• the overall reported rate of non-polio AFP per 100 000 children in European countries in 1996 
had reached 0.7 and this had increased to 1.1 in 1997, with 79% of cases having adequate 
specimens.
Key recommendations
• countries and areas participating in Operation MECACAR generally to continue NIDs as 
Operation MECACAR Plus, and continue in subsequent years unless the risk of cross-border 
transmission is low, routine coverage is consistenly over 90%, and AFP surveillance is sensitive, 
reaching a non-polio AFP rate over 1 per 100 000 and ≥ 80% of cases have timely specimens; 
• other countries and areas, where wild virus has recently been isolated and routine coverage 
is below 90%, additionally to conduct sub-NIDs in areas bordering polio-endemic countries, 
among high-risk populations;
• weekly reporting of line-listed data of all AFP cases to be introduced; and
• active surveillance to be established in countries and areas not yet reaching acceptable passive 
AFP surveillance.
FIFTH COORDINATION MEETING OF OPERATION MECACAR PLUS
Cairo, Egypt, 20–22 October 1998.
Participants
WHO Eastern Mediterranean Region:  Afghanistan, Islamic Republic of Iran, Jordan, Lebanon, 
Pakistan, Palestinian Authority, Syrian Arab Republic. 
WHO European Region: Armenia, Azerbaijan, Georgia, Kazakhstan, Kyrgyzstan, Russian 
Federation, Tajikistan, Turkey, Turkmenistan, Uzbekistan; outside MECACAR: Albania, 
Ukraine, Federal Republic of Yugoslavia. 
Partner organizations: CDC, Rotary International PolioPlus, UNICEF, USAID, WHO.
Context of the fifth meeting
Great progress had been made in many countries and areas in limiting poliovirus transmission 
and improving AFP surveillance. Yet continued transmission in Turkey, despite mopping-up ac-
tivities in 1997 and NIDs in 1998, indicated problems in the quality of the effort. Genetic analy-
sis of recent poliovirus isolates indicated that supplementary immunization efforts had limited 
genetic diversity and supported continued coordinated activities in both regions. Improvements 
in AFP surveillance were not sufficient in the previous year to indicate the extent of areas without 
poliovirus transmission in both regions.
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• in 1997–1998, all countries and areas of the Eastern Mediterranean Region except for Cyprus 
conducted two rounds of NIDs, including Afghanistan. To maximize their impact, NIDs were 
coordinated and synchronized among several groups of neighbouring countries and areas. 
Routine immunization coverage improved to 82%; and
• the European Region continued to report overall OPV3 coverage above 90%. NIDs and sub-
NIDs were implemented in the spring of 1998, achieving coverage of 95%.
Incidence of poliomyelitis:
• in MECACAR countries and areas of the Eastern Mediterranean Region, 1213 polio cases were 
reported in 1997 and 441 in 1998; and
• an historic low of 7 cases of poliomyelitis was reported for the European Region in 1997, 
while the ultimate number of polio cases in 1998 was 26, reported exclusively from Turkey 
(24 type 1, 2 type 3 of the same genetic pool as previous type 1 and type 3 isolates in Turkey 
and surrounding countries). 
Surveillance for cases of acute flaccid paralysis:
• in the Eastern Mediterranean Region, non-polio AFP detection rates were over 1.0 in six of 
eight MECACAR countries and areas and with adequate samples from at least 50% of cases in 
all countries and areas, including Afghanistan; and
• in 1997, rate of reported non-polio AFP per 100 000 children in European countries had 
reached 1.12, with 69% of cases having adequate specimens.
Key recommendations
• all MECACAR countries and areas in the Eastern Mediterranean Region strongly 
recommended to conduct high-quality NIDs in 1999;
• European countries participating in Operation MECACAR to continue NIDs in 1999 unless 
the risk of cross-border importation is low, routine coverage is over 90%, AFP surveillance is 
sensitive, reaching an AFP rate over 1 per 100 000 and ≥ 80% timely specimen collection, and 
wild virus transmission has not been detected for several years;
• mopping-up activities should continue in 1999 in high-risk areas, that is, where wild virus 
has recently been isolated, routine coverage is below 90%, in areas bordering polio-endemic 
countries, and among high-risk populations. Coordination of cross-border activities should 
continue;
• weekly reporting of line-listed data of all AFP cases to be continued;
• active surveillance should be implemented at all health facilities likely to see cases of AFP, and 
overall AFP surveillance and the national laboratories to be further strengthened; and
• Operation MECACAR Plus should continue at least through the year 2000.
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SIXTH COORDINATION MEETING OF OPERATION MECACAR PLUS
Ankara, Turkey, 20–22 October 1999.
Participants
WHO Eastern Mediterranean Region: Afghanistan, Islamic Republic of Iran, Jordan, Lebanon, 
Palestinian Authority, Syrian Arab Republic. 
WHO European Region: Armenia, Azerbaijan, Georgia, Kazakhstan, Kyrgyzstan, Russian 
Federation, Tajikistan, Turkey, Turkmenistan, Uzbekistan; outside MECACAR: Ukraine, Federal 
Republic of Yugoslavia. 
Partner organizations: CDC, Japan International Cooperation Agency, Rotary International 
PolioPlus, USAID, UNICEF and WHO.
Context of the sixth meeting
In the European Region, the last detected case of poliomyelitis associated with a wild poliovirus 
had occurred over 10 months previously on 26 November 1998 in southeastern Turkey. Subse-
quent surveillance for AFP cases yielding a non-polio AFP rate close to 1 per 100 000 children 
had not detected any further cases caused by wild poliovirus. Significant numbers of polio cases 
had continued to be reported from Afghanistan and Pakistan. An extensive epidemic of type 1 
polio, 50 cases till 20 October 1999, had occurred in Iraq of the same genetic lineage as the prior 
cases in Iraq and surrounding countries. Notably, AFP surveillance was now well established in 
all countries and areas.
Main findings 
National immunization days:
• after a gap of two years, supplementary immunization rounds were conducted in the northern 
areas of Afghanistan; and
• NIDs were conducted in seven countries of the European Region where indicated by persisting 
poliovirus transmission or proximity to infected countries.
Incidence of poliomyelitis:
• no poliomyelitis caused by wild poliovirus had been detected in the European Region in 1999; 
and
• in the Eastern Mediterranean Region, 355 cases were reported to 20 October, with Pakistan 
reporting 234; Afghanistan, 55; Iraq, 50; and the Islamic Republic of Iran, 3 (2 being direct 
importations [occurring in a person exposed outside the country], and the third a first 
generation case from another importation from Afghanistan).
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Surveillance for cases of acute flaccid paralysis:
• in the Eastern Mediterranean Region, the overall non-polio AFP rate reached 1 per 100 000 
in 1999; 
• problems in specimen handling, storage and shipment apparently prevented accurate virologic 
confirmation in prior months in Iraq;
• in recently endemic counties in the European Region the overall non-polio AFP rate was 1.51 
per 100 000 children in 1997, 1.13 in 1998 and 0.8 to the end of October 1999. Satisfactory 
specimen collection from cases reached 85% in 1999.
Key recommendations
• the coordination of activities under Operation MECACAR Plus should continue. Two cross-
border coordination meetings to be held in 2000 and a full Operation MECACAR Plus 
meeting in 2001;
• regional communication and advocacy plans to be developed by UNICEF and WHO;
• polio-endemic and recently endemic countries and areas to finalize acceleration plans;
• supplementary immunization to be continued in all countries and areas currently reporting 
endemic polio, plus Turkey and countries bordering Afghanistan;
• AFP surveillance to be intensified in both Regions, including emphasis on active surveillance 
and on “silent” areas; and
• all poliovirus isolates to be submitted for intratypic differentiation and, where appropriate, for 
genomic sequencing to identify patterns of persisting transmission;
• regional plans for the containment of poliovirus stocks to be prepared as soon as possible.
No coordination meeting was  held in the year 2000.
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1993 1994 1995 1996 1997 1998 1999
 NA NA NA   31   45 34 32
   99    96   98   97 100 100 100
   88    87   91   95   92 86 89
   94   96   99 100   98 91 85
   87   92    94   94   92 96 94
   74   65   57   77   74 79 80
   90    89   92   96   95 97 97
   94   94   96   96   96 98 89
 92 92 93 98 95 96 97
 94 95 98 97 98 98 99
 97 94 97 95 96 96 96
 81 82 81 93 98 95 98
 69 75 94 98 100 100 100
 69 83 96 94 99 97 99
 82 88 92 97 91 94 97
 77 92 81 89 92 94 96
 76 81 671    83 79 81 79
 87 87 94 88 99 99 98
 46 75 99 97 98 99 99
routine immunization coverage was markedly increased in most countries and areas (Table 1, 
Fig. 2). While this increase occurred at a time when countries of the former Soviet Union were 
consolidating and strengthening their immunization programmes, it is clear that the introduction 
of coordinated NIDs did not have a detrimental effect on the achievements of routine services and, 
in most areas, appeared to have been beneficial.
1 Fall in OPV3 coverage 
in Turkey in 1995 due 
to shortages in supply 
of DTP and subsequent 
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PLANNING FOR NATIONAL IMMUNIZATION DAYS
Through the coordination of Operation MECACAR and Operation MECACAR Plus, synchro-
nized NIDs were conducted in all MECACAR countries and areas in 1995, 1996 and 1997, and 
NIDs or sub-NIDs in selected countries and areas during 1998–2000.
Eighteen participating countries and areas conducted the NIDs in March–May 1995. Planning 
to ensure success was based on principles developed during the first coordination meeting in An-
kara, in January 1995. These principles included:
• ensuring high-level commitment and consensus;
• guaranteeing adequate resources;
• meticulous planning well in advance of the NIDs themselves;
• involving the private sector, NGOs, religious and other leaders;
• accurate estimating of the target population;
• establishing a cascade effect, with structures and responsibilities defined at each level;
• developing a standard schedule;
• ensuring good logistical support;
• utilizing effective social mobilization techniques;
• making specific arrangements for “special” populations;
• exercising supervision at each level;
• ensuring efficiency and good services at immunization points; and
• planning for evaluation of the activity.
These principles were applied in the planning of NIDs in each successive year. Results suggest that 


















PARTICIPANTS IN OPERATION MECACAR/MECACAR PLUS
During 1995–2000, repeated annual NIDs or sub-NIDs were conducted in the following coun-
tries and areas:
Elsewhere in the Eastern Mediterranean Region, NIDs were being conducted in Bahrain, Egypt, 
Kuwait, Morocco, Oman, Qatar, Saudi Arabia, Sudan, Tunisia and the United Arab Emirates. These 
campaigns were not, however, specifically coordinated with Operation MECACAR  timing. 
In the European Region, Bulgarian authorities had intended during planning to participate only 
in the 1995 rounds of MECACAR NIDs, primarily to help protect its minority populations. In 
1996, the Russian Federation joined Operation MECACAR. All the other countries listed contin-
ued synchronized NIDs in 1996, 1997, and 1998 (sub-NIDs in Kazakhstan and Kyrgzstan). More 
limited activities were conducted in the subsequent years, except in Tajikistan, Turkey, Turkmeni-
stan, and Uzbekistan.
Additional supplementary immunization activities were conducted in countries of the European 
Region during the years of Operation MECACAR  (Figure 3). In 1996, Albania, the Republic of 
Moldova and the Ukraine, conducted NIDs of children under 5 years of age, while Romania con-
ducted phased sub-NIDs. The supplementary immunization rounds in Moldova, Romania and 
Ukraine were coordinated in timing. Albania, later in the year, conducted an outbreak response 
mass immunization with both rounds targeted to persons up to 50 years of age (and reaching 
over 85% of the target). In addition, because of the 1996 outbreak in Albania (138 cases), Greece 
(5 cases) and the Federal Republic of Yugoslavia (24 cases), Bosnia and Herzegovina, Croatia 
(eastern Slavonia) and the former Yugoslav Republic of Macedonia conducted rounds of NIDs 
in 1996–1997, Greece and Italy conducted outreach immunization in the Roma populations and 
Yugoslavia conducted sub-NIDs in a large target age group of school-aged children. In 1997, Al-
bania and Yugoslavia also repeated NIDs/sub-NIDs. Further NIDs were conducted in Albania 
and Ukraine in 1998, as were sub-NIDs in Yugoslavia. Representatives of these three countries 
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participated in the coordination meetings in 1997–1999 as part of Operation MECACAR Plus. 
Greece incompletely implemented NIDs in 1998. Sub-NIDs continued in the former Yugoslav 
Republic of Macedonia in 1999 and in Bosnia and Herzegovina in 1999 and 2000.
SYNCHRONIZATION AND SEASONAL CALENDAR 
OF SUPPLEMENTARY IMMUNIZATION 
Although NIDs were conducted in a synchronized manner during the low season of poliovirus 
transmission, they did not take place on exactly the same dates in all countries and areas. In the 
Eastern Mediterranean Region, Pakistan later coordinated its NIDs with those being conducted 
in India, while the Syrian Arab Republic and Lebanon conducted their NIDs in February and 
March 1997. Both rounds in all countries of the European Region, however, took place within the 
three months of March, April or May. Additionally, synchronized autumn supplementary immu-
nization campaigns were implemented in many countries and areas in 1997–2000. The seasonal 
calendar and extent of supplementary immunization activities for 1995–2000 is indicated for all 
MECACAR countries and areas in Table 2.
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Figure 3.
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entation of this material do not imply the 
expression of any opinion whatsoever on 
the part of the Secretariat of the World 
Health Organization concerning the legal 
status of any country, territory, city or area 
or of its authorities, or concerning the de-






























































































































































































































































































































































































































































































































































































N1:  National 
Immunization Days 
1st round









M1: Mopping-up 1st 
round
M2: Mopping-up 2nd 
round







CB1: Cross Border 1st 
round
CB2: Cross Border 2nd 
round
PN:  Phased National 
Immunization Days, 
phased throughout 
Pakistan in two 
rounds due to delays 
and shortages in 
vaccine supply
Rounds for Sub-NID and 
mopping-up activities may 
be carried out in different 
areas; rounds numbered in 
this table correspond to 
each respective area
NIDs in 1995 and 1996 in 
Afghanistan were 
multiantigen campaigns 
which could not include 
the entire country 
See text for explanations




















































CHILDREN IMMUNIZED DURING NIDS AND SUB-NIDS 
In 1995, during the first NID rounds of Operation MECACAR, 55 million children aged less than 
5 years received two doses of OPV, the coverage achieved being >95% of targeted children.
During the NIDs in the spring of 1996 and 1997 all countries and areas repeated this high achieve-
ment and 60 million or more children received at least two supplementary doses each year. Dur-
ing the years of Operation MECACAR and MECACAR Plus, in addition to some MECACAR 
countries of the European Region modifying the range of participation in the spring campaigns, 
the target age group changed for most countries and areas. The numbers of children in the target 
groups for spring and autumn NIDs and sub-NIDs for 1995–2000 and the reported achievements 
are detailed in Table 3, with the age of the target group varying by country and by year.
CROSS-BORDER ACTIVITIES AND “MOPPING-UP”
Supplementary immunization activities coordinated between countries focusing on bordering 
areas is termed cross-border immunization. Not only were the spring NIDs important in reach-
ing susceptible children and limiting the geographic extent of transmission of wild poliovirus, 
but as a result of the limited circulation of wild poliovirus, more intense, focal activities could be 
undertaken to interrupt transmission. This intense focus on certain areas with house-to-house 
visits by immunizing teams to vaccinate every child is termed “mopping-up”. Starting in 1997, 
mopping-up activities were planned in several border areas and many were preceded by cross-
border coordination meetings. NIDs and sub-NIDs often included intense mopping-up activities 
in high-risk areas and populations, generally using mobile teams going house-to-house to vac-
cinate. Countries and areas monitored the frequency of children receiving the first dose of OPV 
during the mopping-up campaigns (‘zero-dose children’). Because of the uncertainty of specific 
population sizes, the percentage of doses given to ‘zero-dose children’, if low, was found to be a 
more reliable indicator of success than the results of estimated coverage; many countries and ar-
eas also monitored coverage through non-statistically valid surveys of parents in the highest risk 
areas immediately after the campaigns. 
CROSS-BORDER COORDINATION MEETINGS FOR SELECTED COUNTRIES
Although some coordination meetings on polio eradication surveillance activities had been held 
in September 1994 and March 1996 involving participants of Turkey with six MECACAR coun-
tries of the Eastern Mediterranean Region, the regional directors of both the Eastern Mediter-
ranean and European regions determined in a special informal consultation in January 1997 that 
further progress in Operation MECACAR would require specific mopping-up campaigns. In late 
1997, it became apparent that additional coordination of these activities through specific meet-
ings for the key countries would be optimal and allow improved coordination and the sharing of 
achievements. In view of the critical role that the MECACAR cross-border coordination  meetings 
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1 The target age in 1995 
was <5 years (or older) 
in all participating 
countries and areas and 
in subsequent years 
remained <5 years of 
age for MECACAR 
countries and areas of 
Eastern Mediterranean 
Region and for Turkey; 
in other MECACAR 
countries of European 
Region, the target age 
for 1996-1998 was <4 
years of age (in the 
Russian Federation, the 
target age was <3 years 
of age except in the 
northern Caucasus 
territories).
2 Percentage of targeted 
child population 
vaccinated, average of 
the two rounds 
conducted; coverage 
over 100% indicates 
either problems with 
identifying the size of 
the target populations 
and/or includes 
immunizations given to 
older children
3 Northern Governorates 
of Iraq achieved 81 
and 78% in the two 
rounds in 1997 and 
83% in the first round 
in 1998; subsequantly 
these areas’ results are 
included in the country 
result
4 Syria conducted NIDs 
targeting 6 700 000 
children 2 months to 14 
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played in the detailed planning of each activity, each is summarized in the order in which they 
took place. In addition to these meetings, additional meetings of WHO staff with central Asian 
republic immunization programme managers took place to assist in easier access to vaccine sup-
ply for supplementary immunization activities of northern Afghanistan in the autumn of 1998 
and in 2000. 
First coordination meeting on prevention of cross-border transmission of wild poliovirus 
between Islamic Republic of Iran, Iraq, Syrian Arab Republic and Turkey 
Alexandria, Egypt, 3–4 May 1998.
Participants
WHO Eastern Mediterranean Region: Islamic Republic of Iran, Iraq, Syrian Arab Republic. 
WHO European Region: Turkey.
Partner organizations: CDC, UNICEF, WHO. 
Context of the first meeting
With spring NIDs conducted in all countries and areas through Operation MECACAR since 
1995, and autumn sub-NIDs/mopping-up  conducted in southeastern Turkey and border areas of 
the Islamic Republic of Iran, Iraq, and the Syrian Arab Republic in 1997, there remained evidence 
of substantial continuing transmission of wild poliovirus in the area. 
Main findings
• border areas involving the participating countries had historically constituted a single shared 
reservoir for wild polioviruses 
• despite the spring NIDs since 1995 and autumn mopping-up in 1997, there continued to be a 
large number of clinical cases of polio in Iraq and virologically confirmed cases in Turkey. 
Key recommendations
• mopping-up immunization planned for high-risk and border areas of all countries for 
October and November 1998 should be of high quality, with increased planning and 
supervision; 
• all participants will conduct high-quality NIDs in the spring of 1999;
• AFP surveillance activities should be heightened in the border areas of all countries;
• direct channels of communication were encouraged; and
• progress and coordination of future actions should be reviewed at a subsequent coordination 
meeting.
Mobile team 
vaccination in rural 
areas during NIDs, 
Turkey 1999




Second coordination meeting on prevention of cross-border transmission of wild 
poliovirus between Islamic Republic of Iran, Iraq, Syrian Arab Republic and Turkey
Damascus, Syrian Arab Republic, 26–27 August 1998.
Participants
WHO Eastern Mediterranean Region: Islamic Republic of Iran, Iraq, Syrian Arab Republic. 
WHO European Region: Turkey.
Partner organizations: CDC, UNICEF, WHO. 
Context of the second meeting
Because of concern that supplementary immunization activities to date were not sufficiently ef-
ficient in interrupting ongoing endemic transmission of wild poliovirus in the shared reservoir of 
the border areas and populations, enhanced coordinated activities were planned in the high-risk 
areas during the autumn of 1998, with additional detailed planning of logistics (microplanning) 
to be discussed at this meeting.
Main findings
• ongoing transmission of wild poliovirus in unimmunized children in the area of northern Iraq 
and southeastern and eastern Turkey also put the adjacent countries at risk, as well as more 
distant countries and areas of both regions.
Key recommendations
• coordinated mopping-up immunization was planned for high-risk and border areas of all 
countries for the same weeks during October and November 1998; 
• success will require attention to four elements: microplanning at district level, predominant 
use of house-to-house immunization, use of OPV only (not other antigens), and adequate 
logistical support;
• countries should engage in more intensive supervision of activities than in previous 
supplementary immunization activities, with  monitoring and evaluation, including external 
monitoring; and 
• AFP surveillance should improve in border areas, with particular attention to silent areas. 
Third coordination meeting on prevention of cross-border transmission of wild poliovirus 
between Islamic Republic of Iran, Iraq, Syrian Arab Republic and Turkey
Istanbul, Turkey, 1–2 February 1999.
40 O P E R AT I O N  M E C A C A R :  F I N A L  R E P O R T
Participants
WHO Eastern Mediterranean Region: Islamic Republic of Iran, Syrian Arab Republic. 
WHO European Region: Turkey.
Partner organizations: WHO. 
Context of the third meeting
As with the previous coordination meetings on preventing cross-border transmission, planning 
for coordinated and well-supervised mopping-up activities in high-risk areas of southeastern 
and eastern Turkey, as well as the northern areas of the other countries, were to be reviewed and 
discussed.
Main findings
• genetic analysis of wild poliovirus isolates confirmed a decrease in the diversity of circulating 
Type 1 strains in the border populations; and  
• further improvements in the quality of supplementary immunization were needed to 
interrupt transmission completely in the border populations.
Key recommendations
• NIDs must continue in the spring in each referent country;
• the high-risk border populations require house-to-house immunization with mobile teams to 
reach unimmunized children, with microplanning, logistic support, supervision, monitoring 
and evaluation;
• AFP surveillance should be improved in all areas, with active surveillance in the critical border 
populations;
• standard criteria should be used for classification of AFP cases, with all countries and areas 
aiming to apply the virological classification scheme by 2000; and 
• additional immunization and surveillance activities will require additional support of the 
international partners.
Coordination meeting on prevention of cross-border transmission of wild poliovirus 
Baku, Azerbaijan, 23–24 August 1999.
Participants
WHO Eastern Mediterranean Region: Afghanistan. 
WHO European Region: Armenia, Azerbaijan, Georgia, Russian Federation, Tajikistan, Turk-
menistan, Turkey, Uzbekistan.
Partner organizations: Médecins sans Frontières, Rotary International Baku, UNICEF, WHO. 
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Context of this meeting
This meeting focused on planning activities for the Caucasus area as well as the central Asian 
republics. Afghanistan had recently experienced an outbreak with a large number of confirmed 
Type 1 and Type 3 poliovirus positive cases in Kunduz district (bordering Uzbekistan and 
Tajikistan) where sentinel surveillance had recently expanded. 
Main findings
• previous inappropriate handling of specimens in Iraq had apparently prevented virological 
confirmation since mid-1997, but continuing clinical cases and the recent confirmation of 
eight Type 1 poliovirus isolations indicated continuing transmission in the shared border 
population with Turkey;
• extension of AFP surveillance to other areas of Afghanistan might reveal other chains of 
transmission; and 
• risk of importation and cross-border transmission remains in many Caucasus countries and in 
high-risk territories of the Russian Federation in the north Caucasus.
Key recommendations
• coordinated spring NIDs should continue in Afghanistan, Tajikistan, Turkmenistan and 
Uzbekistan, with four rounds planned per year in Afghanistan;
• continued intensive supplementary immunization activities must continue for at least three 
years after the last case in the areas of western Islamic Republic of Iran, northern Iraq, the 
Syrian Arab Republic and southeastern and eastern Turkey;
• in participating countries, repeated supplementary immunization will be necessary even 
without reported polio cases until AFP surveillance meets all performance standards 
throughout the population; and
• the high-risk border populations require house-to-house immunization with mobile teams 
to reach nonimmunized children, with microplanning, logistic support, supervision and 
monitoring and evaluation.
Fourth coordination meeting on prevention of cross-border transmission of wild 
poliovirus between Islamic Republic of Iran, Iraq, Syrian Arab Republic and Turkey
Cairo, Egypt, 2–3 February 2000.
Participants
WHO Eastern Mediterranean Region: Islamic Republic of Iran, Iraq, Syrian Arab Republic; out-
side MECACAR: Egypt. 
WHO European Region: Turkey.
Partner organizations: Rotary International Cairo, UNICEF, WHO. 
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Preparing the cold 
boxes for delivery 




for mopping-up in 
Diyarbakir, Turkey 
1998
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Context of the fourth meeting
The outbreak in Iraq ultimately led to 88 cases (67 virologically confirmed) in 1999. The prob-
lems in transportation of specimens (which may have prevented confirmation of ongoing circu-
lation in 1998) and further improvements in AFP surveillance had been addressed. With intensive 
NIDs conducted in Iraq to counteract declining routine immunization and control the outbreak, 
additional planning and coordination were needed for spring and autumn of 2000 to ensure the 
interruption of wild poliovirus in the area.
Main findings
• Assessment of the NIDs in Iraq in high-risk and other areas indicated suboptimal coverage 
despite high reported coverage; and
• surveillance performance indicators had reached expected standards in all participating 
countries, with indications that sub-national performance was also improving. 
Key recommendations
• in order to ensure reaching previously unvaccinated children with supplementary 
immunization in high-risk areas, house-to-house approaches are necessary. The Ministry of 
Health of Iraq agreed to conduct its next NIDs using house-to-house approaches throughout 
the country; 
• special attention should be given to high-risk, hard-to-reach and cross-border populations, 
and every effort should be made to provide ongoing routine and supplementary 
immunization;
• high-quality intensive supplementary immunization activities should be ensured through 
advanced preparation, detailed microplanning addressing local challenges, performance of 
house-to-house immunization, extensive supervision and monitoring of “zero-dose” children. 
Coordination in timing and activity in cross-border areas are critical; 
• weekly active surveillance must be rigorously implemented;
• suspicion should be heightened wherever AFP is discovered in any child with incomplete 
immunization status, clinical poliomyelitis or exposure outside the area; and
• all countries need to prepare plans for prevention, early detection and control of importation 
of wild poliovirus.
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Coordination meeting on prevention of cross-border transmission of wild poliovirus 
Ashgabat, Turkmenistan, 26–27 July 2000.
Participants
WHO Eastern Mediterranean Region: Afghanistan. 
WHO European Region: Tajikistan, Turkmenistan, Uzbekistan.
Partner organizations: UNICEF, WHO. 
Context of this meeting
Ongoing transmission of poliovirus in Afghanistan required continued vigilance for possible im-
portation across borders, and coordination of supplementary immunization. 
Main findings
• although its borders with central Asian republics of the European Region are generally closed, 
the poliomyelitis situation in Afghanistan remained highly important for polio eradication 
activities in the European Region;
• AFP surveillance had improved in all countries, including the expansion of surveillance 
catchment areas in Afghanistan, although sub-national indicators in some participating 
countries were suboptimal; and
• the number of reported cases in Afghanistan had fallen, despite improved surveillance, due to 
more effective supplementary immunization.
Key recommendations
• coordinated spring NIDs should continue in participating countries up to and including 2002, 
vaccine supply allowing;
• four NIDs rounds should be conducted in Afghanistan each year until transmission becomes 
more localized, primarily using house-to-house vaccination;
• AFP surveillance should be monitored at each sub-national administrative unit;
• priority handling and testing should be given to specimens from children with fewer than 
three doses of vaccine, clinical poliomyelitis, or exposure outside the country; and
• all cross-border cases of AFP should be notified as quickly as possible to the originating 
country and WHO.
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INCIDENCE IN THE EASTERN MEDITERRANEAN REGION
The status of poliovirus circulation in 1990–1995 was complex in the countries and areas of the 
Eastern Mediterranean Region. Routine immunization services could not be established through-
out Afghanistan and poliomyelitis remained endemic, probably throughout the entire country, 
although official reports of cases were not available from 1992 to 1996. In Pakistan, problems in 
sustaining the good achievements of the 1980s in the immunization programme had resulted 
in some decline in infant immunization coverage; poliomyelitis also remained endemic 
throughout the country, although with a marked decrease in reported cases following 
NIDs in 1994 (Table 4). After the marked decline in reported cases following the first 
NIDs, Pakistan again suffered from a major epidemic of poliomyelitis in 1997, reporting 
1147 cases. The epidemic severely affected two provinces, with cases reported from most 
districts.
In Iraq, the disturbances following the Gulf War had resulted in poliomyelitis again be-
coming widespread in the country. In the Islamic Republic of Iran, excellent routine serv-
ices and effective NIDs from 1994 had reduced the incidence of poliomyelitis to almost zero, but 
with repeated importations from Pakistan and Afghanistan. By 1996, it seemed probable that the 
Islamic Republic of Iran, Jordan, Lebanon, the Syrian Arab Republic and Palestinian Self-Rule 
Areas had either stopped transmission or had the potential for such an achievement in the im-
mediate future. Subsequent progress has confirmed this opinion, although the Islamic Republic 
of Iran has indeed continued to experience imported or import-related cases from neighbouring 
Pakistan and Afghanistan, including two such cases in 2000.
INCIDENCE IN THE EUROPEAN REGION
During the period 1990–1995 the reported incidence of acute poliomyelitis in the European Re-
gion had remained between 175 and 369 cases a year (Table 4), reflecting both continuing en-
demic and epidemic spread. The undoubted progress achieved by the increased immunization 





incidence of new 
cases, as well as 
the geographical 
spread.
epidemics, occurring in separate areas. These epidemics appeared to reflect the accumulation 
of susceptible individuals, an inevitability with incomplete immunization coverage. As typical 
examples, epidemics had occurred with the breakdown of reliable immunization services in 
Azerbaijan and Uzbekistan and later in the Russian Federation (in Chechnya) (Table 4).
If Operation MECACAR NIDs were effective, it was anticipated that the number of susceptible 
individuals within any country, even within all communities, would be reduced to such a low level 
that wild poliovirus transmission would be unlikely to be sustained. To a great extent this is what 
happened as Operation MECACAR progressed and, in the European Region, the major epidem-
ics of 1995 and 1996 occurred in countries not originally participating in Operation MECACAR. 
The Russian Federation joined Operation MECACAR from 1996 following the outbreak in the 
under-vaccinated population of Chechnya in 1995. Because of substantial problems in Albania 























1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 20001
   48     2   NA   NA   NA  NA  NA  19 59 150 107
   15   55    44   107    93  101   12        13   4 32 22
   56 186  120     75    63    34 24   34        37   88 4
     0   14    18       0      4      0 0 0 0   0     0
     2     5   NA       0      2 0      0     0    0   0     0
 777    1147 1046 1803  527  508 341        1147 341 558 159
   13   24     22       0      2      4     0    0   0 12 0
 NA NA   NA   NA   NA   NA  NA    0   0     0 0
911     1433 1250 1985  691  647 377        1213 441 796 270
1499 2129 1901 2451 1015  798 535       1261   554 910 425
   12     3     1    0    5    3   0   0   0   0 0
 182 21 22   69 16    5   0   0   0   0   0
 31 6 0    0   0    0   0   0   0   0   0
     7     5     6    1   4    1   0   0   0   0  0
     1     4     5 0    0   0      0   0    0   0   0 
   12   11   4    1   2 150   2   0   0   0    0
     2 115     5  14 26    0   0   1   0   0 0
   21   25   25  24 32  32 19   6  26 0 0
   40   16     4    2   6    8    2 0   0   0   0
 42 20 11 68 117 1   0   0   0 0 0
350 226   83      179 208 200 23 7 26 0 0
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Table 4.
Reported number of 
poliomyelitis cases 









cases not included in 
totals.
to an accumulation of susceptible adults and children, the outbreak of poliomyelitis in 1996 oc-
curred following introduction of wild poliovirus from outside the European Region despite ear-
lier NID vaccination of children under 5 years of age; in the Federal Republic of Yugoslavia, cases 
occurred in the ethnic Albanian population who had long-standing problems accepting child im-
munization services provided by the Yugoslav government. 
In addition to the much reduced incidence of new poliomyelitis cases, Operation MECACAR 
made a significant impact in reducing the geographic extent of endemic disease, reflected by a 
marked decrease in the number of known infected countries/areas or geopolitical units within 
countries, such as provinces, governorates or districts (Table 5, Fig. 4).
1990 1499 Baseline  8  911 
1991 2129 +42% 8  1433 
1992 1901 +27% 7  1250 
1993 2451 +64% 6  1985 
1994 1015 -32% 6  691 Baseline
1995 798 -47% 5  647 -6%
1996 535 -64% 4  377 -45%
1997 1261 -16% 4  1213 +76%
1998 554 -63% 8 118 441 -36%
1999 9102 -39% 7 195 7962 +15%
20003 4252 -72% 6 113 2702 -61%
1990            369 Baseline   16  350
1991 313 -15%       15  276
1992      175 -53% 14 105 83 
1993  202 -45% 14 64 179  
1994 231 -37% 13 74 208 Baseline
1995 206 -44% 10 43 200 -4%
1996        192 -48% 8 45 23 -89%
1997       7 -98% 2 2 7 -97%
1998 26 -93% 1 5 26 -88%
1999 0 -100% 0 0 0 -100%
20003 0  0 0 0
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Trend analysis of 
reported cases of 
poliomyelitis by each 
entire WHO region, 
by districts and in 




1 Districts defined 
differently by each WHO 
region.
2 Not including 4 imported/
import-related cases in 
1999 and 2 in 2000. 
3 Provisional data through 
January 2001.
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Figure 4.
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Willing but con-
cerned participant 





AFP SURVEILLANCE PERFORMANCE INDICATORS
Fully operational AFP surveillance meeting all performance indicator standards is a highly valu-
able tool both for promptly detecting wild poliovirus circulation as well as for providing evi-
dence over time on the absence of poliovirus circulation when transmission has indeed been in-
terrupted. The background rate of flaccid paralytic illnesses of recent onset provides a measure 
of the expected incidence of disease not due to wild poliovirus for assessing surveillance sensitiv-
ity. Virological testing in WHO-accredited laboratories of faecal specimens adequately taken and 
handled provides a solid basis for disconfirmation of poliovirus infection as a cause of the paraly-
sis. In order to be effective, all steps in virologic surveillance must function well, from the field in-
vestigation, specimen collection and handling to the testing of specimens in a laboratory that has 
proven sensitivity and accuracy, backed up by viral characterization in the reference laboratories 
of the global polio network. The training, monitoring, supervision, evaluation and problem solv-
ing which have taken place in MECACAR countries and areas, supported by the polio partner-
ship, has taken the quality of surveillance and virologic testing to very high levels. 
A recommendation was made at the first coordination meeting, held in January 1995, that high 
priority be given to AFP surveillance, including linking virological investigations to epidemio-
logical data on AFP and suspected poliomyelitis cases. The second coordination meeting, held in 
September 1995, further discussed the WHO criteria by which surveillance should be evaluated, 
including timely receipt of reports, aiming to achieve a rate of non-polio AFP case detection at 
or above 1 per 100 000 children aged under 15 years, 80% case investigation within 48 hours, col-
lection of two faecal specimens within 14 days of onset on at least 80% of AFP cases and high 
60-day follow-up of cases. The meeting also defined criteria for the evaluation of virological sur-
veillance, including assessment of laboratory competence, and of timely specimen collection and 
transportation. Finally, the meeting recommended the regular monitoring of such performance 
indicators. The meeting recommendations specified that the countries and areas reaching a non-
polio AFP rate of 1 per 100 000 with two specimens collected within 14 days from at least 65% 
of AFP cases should switch to a virologically based AFP case classification. Participants also 

























Polio cases, all European Region
Polio cases, European MECACAR
AFP cases, all European Region
Polio cases, all Eastern Mediterranean Region
Polio cases, Eastern Mediterranean MECACAR











































56 O P E R AT I O N  M E C A C A R :  F I N A L  R E P O R T
recommended that virological services should 
be made available to all areas by strengthening 
national laboratories or through rapid trans-
portation of specimens to accredited labora-
tories in other countries. The third coordina-
tion meeting, held in October 1996, re-em-
phasized the main performance indicators by 
which surveillance should be evaluated. In ad-
dition it was indicated that the extent of sur-
veillance should cover the whole population 
so that sub-national analysis of the main in-
dicators reflect a high level of surveillance in 
all populated areas. The data on numbers of 
polio cases in MECACAR countries and areas 
of both regions for 1990-2000 as well as total 
number of polio cases and total AFP cases in all 
countries and areas of both regions are sum-
marized in Fig. 5. The data on annual primary 
AFP surveillance indicators in MECACAR 
countries and areas for the period 1996-2000 
are given in Table 6 and Fig. 6.
STATUS OF SURVEILLANCE IN 1996
By the third coordination meeting, in Octo-
ber 1996, the Eastern Mediterranean Region 
reported that all except one of the MECACAR 
countries and areas of the Region were con-
ducting AFP surveillance and that two, Jordan 
and the Islamic Republic of Iran, had detected 
non-polio AFP rates over 1 per 100 000. The 
Regional Office was regularly publishing a 
newsletter, “POLIOFAX”, with data on the in-
cidence of detected AFP and confirmed polio 
cases. Nineteen countries in the European Re-
gion were routinely reporting AFP surveillance 
data. The overall non-polio AFP rate had in-
creased from 0.24 to 0.53 per 100 000 children 
for the Region.
Figure 5.
Reported cases of 
poliomyelitis and 
total AFP in 
countries and areas 
of the WHO Eastern 
Mediterranean and 
European Regions, 
and reported cases 
of poliomyelitis in 
MECACAR 
countries and areas 
of each region, 
1990-2000
1 Not including 4 
imported/import-related
cases in 1999, 2 in 2000. 
2 Provisional data through 
January 2001.
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1997 NA 0.10 0.66 0.67 1.19 NA   46  50 53 49
1993 1.55   1.30 1.43 1.14 1.15  66   80   76 77 69
1994 0.42   1.80 1.19 1.66  2.41 39   76   72 80 85
1993 1.00   1.40   1.80 1.56  1.34 85   67   76 83 92
1994 0.38   0.30 1.26 1.60  1.26 60   67     0 21 91
1995 0.34 0.73 0.71 1.22  1.48 56   43   61 70 73
1993 1.20 1.18 1.32 1.27  1.50 67   83   98 82 81
1995 0.73 1.03 1.21 1.00  0.69 NA   75 100 92 100
1995 0.75 1.45  2.05 2.48 2.37 100   93 68 91 86
1994 0.50 0.54  0.51 0.90 0.68    0   77 67 86 94
1996 0.69 0.55  1.32 0.82 1.57  22   86 81 70 89
1992 2.18 0.69  1.29 0.99 1.41 100   60 74 85 85
1995 0.68 1.39  1.25 1.18 1.43     100   63 70 79 87
1992 1.04 2.76  1.24 1.91 1.70  72   71 69 79 87
1996 0 0.67   0.75 1.55 1.59     0   71 63 87 83
1991 0.32 0.62    1.13 1.18 1.27  34   65 70 79 84
1995 0.56 0.56  1.38 2.22 1.98  67   56 57 78 97
1996 0.08 0.15  0.97 1.19 1.23   29   86 87 90 89
Table 6.
Non-polio AFP rate 
in children aged 
< 15 years and 
specimen collection 
in MECACAR 
countries and areas, 
1996-2000
1 Reported data before 
1997 for the European 
Region (1998 for Russian 
Federation) may include 
cases of isolated facial 
paralysis as AFP, which 
were not included 
subsequently.
2 Provisional data reported 
through January 2001.
3 Reduced reported 
percentage of specimen 
collection within 14 days 
in some countries of the 
European Region due to 
improved data quality 
control since 1998.
The participants concluded that, for 1997, the highest priority was to institute or improve AFP 
surveillance and that an equally high-priority was to improve the laboratory network to ensure 
adequate laboratory support for each country.
STATUS OF SURVEILLANCE IN 1997
By the fourth coordination meeting, in October 1997, MECACAR countries and areas in the East-
ern Mediterranean Region had made significant progress towards developing effective surveil-
lance. Six of the eight countries were provisionally reporting non-polio AFP rates above 1 per 
100 000 in 1997, the two not doing so being Afghanistan, where surveillance was virtually impos-
sible, and Lebanon, whose small population make target rates unstable. Ultimately, Pakistan also 
reported below 1 case per 100 000 for 1997. Throughout the Region, over 60% of detected AFP 
cases had adequate samples obtained within 14 days of onset of paralysis.
 19961 1997 1998 1999 20002 1996 1997 19983 1999 20002
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AFP detection increased throughout the European Region, reaching an annualized rate of non-
polio AFP for 1997 of 1.1 per 100 000 children compared with a final rate of 0.7 in 1996. It was 
later determined that many Member States of the European Region often included cases of iso-
lated facial paralysis (no limb paralysis) as AFP, falsely increasing the reported non-polio AFP 
rates. Thirty-two countries now reported having an AFP surveillance system, increasing from 25 
in 1995 and 30 in 1996. In 1996, only two out of the ten MECACAR countries in Europe had 
reached an AFP rate above 1 per 100 000, but this had increased to four provisionally in 1997. 
Performance indicators were by this time being regularly published in a “EURO POLIO PAGE”, 
providing feedback to countries. There was wide disparity among countries, however, the overall 
proportion of AFP cases with two specimens within 14 days had reached 79% for 1997. The re-
gional laboratory network performance remained suboptimal in terms of national laboratories 
meeting WHO-accreditation criteria as well as in the flow of information and isolates for confir-
mation and characterization by the regional reference laboratories.
Participants at the meeting, acknowledging that surveillance was now established and had im-
proved significantly, recognized that it had still not reached the levels required for eventual certi-
fication of poliomyelitis eradication. They also agreed that national aggregate data could be con-
cealing differences between geopolitical subdivisions and that continued focal transmission in 
these areas remained a possibility. This focus on strong surveillance performance indicators in 
sub-national areas requires careful monitoring and supervision in each country. The participants 
also acknowledged that the laboratory network had become established, but regretted that few 
laboratories had yet obtained accreditation. Finally, the meeting reviewed options for surveil-
lance in geographic areas with high-risk populations and where access was limited or difficult. 
These options included specific time-limited activities aimed at AFP surveillance and collection 
of specimens from contacts if detection of the case had been delayed, where problems had re-
sulted in low AFP case detection or in areas where polio-compatible cases had occurred. The pos-
sibilities of introducing active case-searching, ensuring high-quality “zero” reporting, and retro-
spective hospital record reviews were also discussed.
STATUS OF SURVEILLANCE IN 1998
Provisional data for 1998 were discussed at the fifth coordination meeting in October 1998. In 
the Eastern Mediterranean Region, AFP surveillance had continued to improve rapidly in critical 
areas. During 1997-1998, AFP surveillance had been functioning or initiated in all MECACAR 
countries and areas of the Eastern Mediterranean Region. In Afghanistan, AFP surveillance was 
initiated in 1997 and the non-polio AFP rate provisionally reached 0.67 per 100 000 in 1998. The 
sensitivity of surveillance, indicated by the regional average non-polio AFP rate, improved from 
0.85 per 100 000 in 1997 to 0.9 per 100 000 in 1998. In 1998, six of the eight MECACAR countries 
of the Region had achieved or exceeded the recommended minimum non-polio AFP rate of 1.0 
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per 100 000. Adequate stool specimens were collected from 66% of all AFP cases reported in 1998 
by the eight MECACAR countries and areas of the Region.
In the European Region, AFP surveillance continued to improve. Based on these improvements, 
all countries of the Region converted to a virological scheme for classification of AFP cases for 
1997 and onwards (except Tajikistan which used a virological classification scheme from 1999 and 
onwards). In 1998, AFP surveillance was operational in 35 countries, including all the MECACAR 
countries in the Region. The regional average non-polio AFP rate ultimately was 1.02 per 100 000, 
with adequate stool specimens obtained in 74% of cases, compared to a non-polio AFP rate of 
1. 12 per 100 000 and adequate stool specimens obtained in 69% of cases in 1997. Data for the 
Russian Federation and Ukraine for 1997 included cases of isolated facial paralysis, whereas other 
countries’ final annual data for 1997 (and all data for 1998 and later) excluded such cases. Weekly 
case-based reporting of information on AFP cases (or the absence of AFP cases) to the WHO Re-
gional Office was implemented by 31 countries. Independent assessments of quality of AFP sur-
veillance conducted in 14 countries of the European Region (including all MECACAR countries 
except Tajikistan), showed that AFP surveillance improved in almost all high-risk areas of the 
Region, particularly in Armenia, Turkey and Turkmenistan, and highlighted opportunities for 
further improvement in those countries as well as in others not meeting performance criteria.
The recommendations from the fifth coordination meeting re-emphasized the value of surveil-
lance monitoring and evaluation and ongoing data analysis in highlighting areas for improve-
ment towards achieving the targets for surveillance performance indicators.
STATUS OF SURVEILLANCE IN 1999
Provisional data for 1999 were discussed at the sixth coordination meeting in October 1999. All 
the countries and areas of the Eastern Mediterranean Region had established a system of AFP 
surveillance, including countries and areas in civil conflict and war. During 1999, AFP surveil-
lance continued to improve throughout the Region and for the first time the AFP rate exceeded 
1 per 100 000 children under 15 years as compared to rates of 0.49 in 1994, 0.71 in 1996 and 
0.88 in 1998. The overall adequate stool specimen collection indicator was 67% for the Region. 
More countries and areas reached the required level of AFP surveillance sensitivity. The quality 
of surveillance in countries and areas of the Region that were at high risk of virus importation, 
notably the Islamic Republic of Iran and the Syrian Arab Republic, was high and systems in these 
countries and areas had already demonstrated their ability to detect virus importation promptly.
In the European Region, AFP surveillance improved further in 1999. The regional average non-
polio AFP rate was 1. 17 per 100 000, with adequate stools specimens obtained in 74% of cases. 
Of the 17 recently endemic countries, including all MECACAR countries, all but four (Albania, 
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Azerbaijan, Bosnia and Herzegovina and Georgia) were approaching or exceeding the sensitivity 
and specimen collection standards of AFP surveillance. All 39 countries conducting AFP surveil-
lance were reporting case-based AFP surveillance data weekly to the Regional Office. By the end 
of 1999, completeness of weekly reporting was 86% and timeliness was 82%. Training and as-
sessment programmes continued, with emphasis being placed on monitoring AFP surveillance 
performance in sub-national areas to allow appropriate targeting of corrective interventions.
The participants agreed that the surveillance indicators were improving, approaching certifica-
tion quality standards and that all prior recommendations must continue to be applied. Monitor-
ing of sub-national indicators remains important, as does attention to prompt shipment of faecal 
specimens in appropriate conditions to the designated, accredited laboratory.
STATUS OF SURVEILLANCE IN 2000
In the Eastern Mediterranean Region, the provisional non-polio AFP rate reached 1.33 per 
100  000 children under 15 years in 2000. The percentage of AFP cases with adequate stool speci-
mens reached 70% overall in 2000. The number of countries and areas reporting 80% or more 
AFP cases with adequate stool samples increased. The quality of surveillance improved sub-na-
tionally. A computerized regional database was developed to include information on all AFP 
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cases. All countries and areas had computerized databases and were reporting weekly data on AFP 
and on laboratory results.
In the European Region, the progress seen in 1999 continued, with all but three recently 
endemic countries meeting the sensitivity and specimen collection standards of AFP sur-
veillance (Albania, Azerbaijan [with high specimen collection], and Bosnia and Herze-
govina). The provisional regional average non-polio AFP rate was 1. 12 per 100 000, with 
adequate stool specimens obtained in 80% of cases; the provisional averages for the 17 re-
cently endemic countries were 1.40 and 87%, respectively. Support to country workshops, 
surveillance supervision and specimen transport action continued with improved sub-
national indicators of AFP surveillance activities. Completeness of weekly reporting was 
91% and timeliness was 81%.
THE POLIO LABORATORY NETWORK 
To provide meaningful data, virologic testing of faecal specimens needs to be in a labora-
tory that is sensitive, accurate and provides results in a timely manner and therefor WHO 
has set objective criteria for annual laboratory accreditation. National laboratory findings 
are confirmed in regional reference laboratories, which also determine whether poliovirus iso-
lates are derived from OPV or are wild poliovirus (intratypic differentiation). Such differentia-
tion is conducted at three laboratories for MECACAR countries and areas of the Eastern Medi-
terranean Region and at two regional reference laboratories for MECACAR countries of the Eu-
ropean Region. Specialized laboratories conduct genomic sequencing to determine the familial 
origin and derivation of wild poliovirus isolates. These various laboratories constitute the polio 
laboratory network. Timely transport to each laboratory under appropriate conditions is moni-
tored and continues to improve, although some weaknesses persist. Substantial efforts have been 
made to provide appropriate equipment, supplies, cell lines and training of staff for network lab-
oratories to strengthen performance, supported by the coalition of international partners, which 
has allowed the polio network to reach high levels of performance for each region.
In the Eastern Mediterranean Region, there are five countries with WHO-accredited national lab-
oratories in the eight MECACAR countries and areas. These have been fully accredited since 1998 
(except for Iraq, in 1999). In the European Region, there are five national laboratories in the ten 
MECACAR countries. Of the five national laboratories, all but one were WHO-accredited since 
1999. In the Russian Federation and Turkey, there are also sub-national laboratories that also 
must meet annual accreditation criteria. Through appropriate transportation and inter-country 
collaboration, all specimens from AFP cases in the Eastern Mediterranean Region have been 
tested in accredited laboratories since 1998 (including cases in Iraq) and in the European Region, 
since the end of 1999.
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opening the NIDs 
with political and 
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Bulgaria 1995
Apart from the impact of the coordinated activities on the incidence of poliomyelitis, per-
haps the most striking phenomenon in Operation MECACAR, and a major factor in its 
success, was the development and guarantee of partnership among all agencies – and usu-
ally individuals, as well.
Because the MECACAR countries and areas of the two WHO regions involved have many 
different characteristics, the regional offices also needed to function in different ways. Yet 
the common planning in Operation MECACAR, problem-solving through shared experi-
ence, coordination of joint activities and free sharing of information (including changing 
national plans for supplementary immunization and up-to-date surveillance data), made 
the already strong partnership between the regional offices (and with the WHO global co-
ordination team for the poliomyelitis eradication initiative) even stronger operationally. 
Fulfilment of partnerships in Operation MECACAR occurred at many different levels, but 
falls into two categories, that occurring within countries and areas and that which was 
predominantly international.
NATIONAL PARTNERSHIPS
Within each country, the responsibility for Operation MECACAR-related activities rested with 
the various ministries of health. The implementation of NIDs, however, permitted a largely un-
precedented liaison to take place between many different individuals, institutions and ministries 
and among various sectors of public life. While it is impossible to define each contribution, most 
areas benefited from the inputs of certain key individuals in a number of ways:
• at the national level, heads of state, government ministers, and religious and other leaders 
endorsed the campaigns, frequently providing public endorsement by giving the first vaccine 
dose in the annual campaigns;
• at a more peripheral level, leading public figures provided similar endorsement within their 
own communities;
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• public personalities in the media, theatre and, notably, sports encouraged parents to cooperate 
in protecting their children. With their personal followings, this was always an important 
contribution;
• television and radio stations gave much broadcast time, informing the public of the campaign 
details and objectives, the background of immunization, poliomyelitis as a disease, even the 
need for surveillance;
• other ministries gave time, support, staff and additional resources to allow health staff to reach 
all communities. In a number of countries and areas, the armed defence services cooperated in 
the campaigns, providing means of transport such as land vehicles or helicopters to transport 
staff or vaccine to distant communities; and
• a major contribution was through the involvement of community groups, women’s 
associations, Rotarians, scouts, and others, who had a key role in informing, motivating and 
actually providing support during immunization sessions.
Without these massive and well-coordinated inputs, the consistently high coverage rates reported 
could not have been achieved. A whole range of non-health personnel clearly demonstrated their 
willingness to be involved in a programme aimed at the health of the country’s children.
INTERNATIONAL PARTNERSHIPS
While the inputs within the countries and areas allowed successful implementation of NIDs, mop-
ping-up activities and, later, the development of surveillance services, careful, well-coordinated 
planning had already taken place months before the first drops of vaccine were administered.
There were two key elements in this advance planning:
• the successful holding of coordination meetings each year, attended by both national and 
international staff. As the authorities responsible for operational activities, participation 
of national representatives provided the key element in making these meetings successful 
by sharing experiences, making proposals, defining resource needs and constraints, and 
determining future policies and priorities; and
• the willingness of the international agencies to plan details together, to commit staff to joint 
activities, to provide substantial financial, technical and personnel resources for Operation 
MECACAR, including vaccine purchase and, above all, to work quickly and effectively in the 
development of efficiently organized campaigns.
The contributions of the different agencies were significant and varied from country to country. 
As a brief and incomplete summary, the following contributions were consistently made, with 
each agency ensuring its support to guaranteeing the success of Operation MECACAR:
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World Health Organization
Technical assistance:
✔ Overall coordination of Operation MECACAR
✔ Planning
✔ Technical and programme guidance
✔ Guidelines and standardization
✔ Outbreak investigation
✔ Guidance and support for coordination meetings
✔ Laboratory network coordination and accreditation
✔ Monitoring and development of reporting systems 
✔ Training in surveillance
✔ Evaluation
✔ Feedback and information
✔ Promotion of political support
✔ Framework for certification and containment
Financial support:
✔ Technical support staff
✔ Training
✔ Evaluations
✔ Monitoring and supervision
Rotary International PolioPlus Programme
Technical assistance:
✔ Advocacy at all levels for poliomyelitis eradication
✔ Community contacts and influence, including among minority groups
✔ Volunteer support to immunization centres during NIDs
✔ Incentives and promotional items




✔ Incentives and promotional items
✔ Operational support, allowances
✔ Surveillance activities of AFP
✔ Vehicles
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✔ Poliomyelitis laboratory equipment and supplies, support for training
✔ Central coordination staff at WHO
✔ Other areas of immunization services (including hepatitis B vaccine)
Many other nongovernmental organizations, such as the International Federation of Red Cross 
and Red Crescent Societies, Médecins sans Frontières, Medical Emergency Relief International 
(Merlin), Doctors of the World and International Medical Corps provided technical assistance 
and operational support in many countries and areas where they were working. In addition, the 
United Nations Foundation has provided support to the regional offices for supplementary im-
munization operational expenses, the certification process and coordinating the laboratory con-
tainment of wild polioviruses.
United Nations Children’s Fund (UNICEF)
Technical assistance:
✔ Planning
✔ Technical support at regional and national levels
✔ Training
✔ Cold chain assessment and development
✔ Evaluation
✔ Assistance in evaluating resource needs
✔ Development of reporting
✔ Social mobilization
✔ Major assistance in negotiating “days of tranquillity”.
Financial support:
✔ Technical support staff
✔ Vaccine
✔ Cold-chain equipment
✔ Transport and allowances where needed.




✔ Assessment of surveillance
✔ Outbreak investigation
✔ Special virology laboratory investigations and consultations
✔ Epidemiological and laboratory expertise when required.
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Financial support:
✔ Vaccine
✔ Training in surveillance
✔ Laboratory equipment and supplies (with USAID) 
✔ Central coordination staff at WHO
✔ Country surveillance activities
✔ Communication and feedback (publications and coordination meetings).




✔ Assessment of cold chain
✔ Managerial training
✔ Social mobilization




✔ Technical and personnel support for the polio laboratory network
✔ Country surveillance activities 
✔ Communication and feedback (publications and coordination meetings)
✔ Other areas of immunization services
 – Cold-chain evaluations and strengthening
 – Regional interagency committee support
 – Self-sufficiency and procurement training
Bilateral Agencies
Many governments through their development agencies provided a range of support, most nota-
bly for vaccine and for strengthening national laboratory services. These governments included 
Canada, Denmark, Finland, France, Italy, Japan, the Netherlands, Norway, Switzerland, and the 
United Kingdom.
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FEEDBACK ON PARTNERSHIP FROM INDIVIDUALS 
AND ORGANIZATIONS PARTICIPATING IN OPERATION MECACAR
National and international representatives participating in the sixth coordination meet-
ing, held in Ankara in October 1999, devoted a full plenary session to discussing part-
nership. As the individuals and the organizations most intimately involved in Operation 
MECACAR, their experiences and opinions are not only critical in appraising factors lead-
ing to the success of the initiative but also for potential application in future partnerships.
A questionnaire had been previously circulated to 12 countries and areas (ten in the Eu-
ropean Region and two in the Eastern Mediterranean Region). All survey respondents be-
lieved that the Operation MECACAR partnership was important or critical for the success 
observed and also that partner coordination at the national level was important. The es-
sential components of success were considered to be leadership – of the national immuni-
zation programme managers and of the WHO regional offices – and clear regional and 
national objectives and plans. The factors cited as particularly critical for the successful 
partnership of Operation MECACAR were: the responsiveness of partners to government 
requests; regular feedback on programme outcomes; transparency and accountability of 
fund use; the opportunity for dialogue; and openness to suggestions. The respondents also 
indicated that the coordination and partnership of Operation MECACAR could be further im-
proved by capitalizing on the individual strengths of each partner agency identifying partners 
with common interests, and by enhancing transparency and information sharing.
Additional points made during discussion of this session in Ankara were:
• partnerships are very valuable for enhancing technical quality, human and financial resource 
mobilization, avoiding duplication and maintaining advocacy;
• effective partnership requires leadership, information flow and feedback, and opportunities 
for recognition;
• partnerships are most effective when common goals are defined, short and medium-term 
plans of action prepared and detailed budgets established;
• for optimal effect, partnerships are necessary at the international, regional, national and sub-
national levels;
• establishing effective national interagency coordinating committees could assist in a range of 
health interventions;
• the frequency of common meetings, the agendas and the selection of appropriate participants 
are critical if programme needs are to be defined and the realities of implementation are to 
be properly included in planning;
• where various sanctions, political or financial, exclude the possibility of full partnership, 
informal discussion in coordination meetings is still valuable;
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• Operation MECACAR was widely seen as very effective in developing consensus on technical 
issues, coordinating supplementary immunization activities across borders, providing 
feedback and sharing lessons learned among countries/areas;
• most participants felt that Operation MECACAR meetings should continue in order to discuss 
a range of cross-border issues and to continue sharing experiences and lessons learned;
• cross-border meetings allow the addressing of immediate operational constraints most 
effectively when participants are from epidemiological blocks, that is, with common 
geography, epidemiology, levels of development and access to services;
• there is a clear need for improved communication and shared objectives among all operational 
staff such as immunization programme managers, laboratory staff and also those with 
responsibility for social mobilization;
• the more recent coordination meetings of Operation MECACAR had not been as successful in 
immediately mobilizing resources, attracting new partners or in providing opportunities for 
political advocacy as had earlier meetings; and 
• specifically for Operation MECACAR, the recent lack of additional involvement of bilateral 
donors and foundations as its successes increased was noted with regret and it was suggested 
that WHO should increase dialogue with such agencies.
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Operation MECACAR has been an overwhelming success. The coordination and the partnership 
exemplified within the Operation have been extended to other WHO regions, with the Eastern 
Mediterranean and African regions coordinating NIDs in the countries of the horn of Africa since 
May 1999 and with the recent efforts in all western and central African countries to synchronize 
NIDs.
Within the European Region, poliomyelitis caused by wild poliovirus has been apparently elimi-
nated from the MECACAR area. The last case of poliomyelitis to date in the European Region 
occurred on 26 November 1998 in eastern Turkey. The underlying weaker routine immunization 
services of southeastern and eastern Turkey and shared population subgroups across borders al-
lowed the circulation of polioviruses there to continue longer than in other areas of the Region. 
However, by improving both surveillance and the quality of supplementary immunization activi-
ties from the autumn of 1998 onward (through enhanced planning, supervision, monitoring and 
logistical support), workers were able to reach previously unimmunized children. Coordination 
of activities across borders with neighbouring countries, including Iraq, is and will continue to 
be important to ensure the interruption of transmission in the entire area of shared population 
subgroups. Proof of the interruption of poliovirus transmission will demand further observation 
and strengthening of surveillance and virological testing of all childhood cases of AFP. 
Within the MECACAR countries and areas of the Eastern Mediterranean Region there has been a 
dramatic decline in reported polio cases, in spite of substantial strengthening of surveillance and, 
therefore, more complete reporting. Among the eight participants of Operation MECACAR in 
the region, five – the Islamic Republic of Iran, Jordan, Palestinian Self-Rule Areas, Lebanon and 
the Syrian Arab Republic– have no evidence of continuing endemic transmission. In 1999 and 
through to early 2000, Iraq had virological evidence of ongoing transmission but energetically 
responded to control and interrupt poliovirus circulation. The last reported case in Iraq with viro-
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2. Achieve polio elimination.
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5. Advancement of reporting 
systems.
6. Promotion of partnership.
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8. Promotion of enhanced 
intercountry cooperation 
for the control of other 
communicable diseases.
Level of achievement
Achieved completely in all countries and areas where access to all 
communities was possible: logistic support and supervision now 
enhanced to extend access to children of all areas.
While probably achieved in most countries and areas, this is 
not yet complete and will require continued activities until the 
objective is finally met.
This is now established in all countries and areas and is both 
detecting AFP cases and achieving improved effectiveness, as 
shown by current performance indicators. Without Operation 
MECACAR, this would have taken much more time.
This is established and is now capable of investigating samples 
from a high percentage of AFP cases with high accuracy. Although 
all specimens from AFP cases since 1999 have been examined in 
WHO-accredited laboratories in both WHO regions, there is still 
a requirement for further accreditation and for better liaison 
between laboratory and operational staff.
Successful. All countries and areas are now reporting weekly to 
WHO and are using performance indicators to monitor progress 
and technical achievement.
The promotion of partnership between countries/areas and 
agencies and among agencies has been conspicuously successful, 
with much improved joint planning and consultation both in the 
coordination meetings and as a routine.
National committees to evaluate and submit data to the regional 
certification commissions for eventual certification of polio 
eradication have now been established in almost all countries and 
areas. National surveillance systems are routinely gathering data 
that will be essential for eventual certification.
This has not yet been well developed, although there is little 
doubt  that the mechanisms put in place for polio eradication have 
helped in the campaign to control diphtheria and will be vital if 
improved measles control/elimination is to be a reality.
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prompt testing of specimens, indicating likely interruption of transmission. This could mean 
the extinction of the type 1 genotype previously circulating in the border areas of this and neigh-
bouring countries. Pakistan has a markedly reduced incidence throughout the country. The in-
crease in reported cases in Pakistan in 1997–1999 reflects both the occurrence of a widespread 
epidemic in 1997 and progressively improved AFP surveillance over time, which resulted in cases 
being more consistently and completely detected and reported. Despite even stronger AFP surveil-
lance in 2000, a record low number of polio cases has been provisionally reported. In Afghanistan, 
data are too incomplete to be able to assess levels of transmission, but the fact that supplementary 
immunization has progressively developed into countrywide NIDS is remarkable in itself; also 
noteworthy is the fact that surveillance has developed to the current extent, with fewer cases being 
provisionally reported in 2000 than in 1999 despite these improvements in the extent of surveil-
lance.
Although there appears to be a less dramatic impact of Operation MECACAR in portions of the 
Eastern Mediterranean Region than in the European Region, the results are actually consistent. 
In Pakistan and in Afghanistan, baseline immunization coverage in 1994 and some years subse-
quently was at a much lower level than in the European MECACAR countries. Accordingly, on 
average, children have received fewer doses of OPV and the protective effect is proportionally 
less. In addition, problems imposed by conflict, crowding and poor standards of hygiene can all 
contribute to a reduced impact of the NIDs. It can be expected that continuing the same strate-
gies in these countries (acceleration of the number and particularly the quality of supplementary 
immunization rounds) will, shortly, produce a similar result. 
The Operation has been no less successful in meeting secondary objectives. Laboratory-supported 
AFP surveillance, although still incomplete in some critical areas, is now well established and is in 
the process of providing data for the eventual certification of poliomyelitis eradication. The panel 
opposite summarizes the perceived achievement of the objectives defined earlier in this report.
FACTORS CONTRIBUTING TO OPERATION MECACAR’S SUCCESS
Technical basis
The principle on which Operation MECACAR was conceived – that is, the coordinated and syn-
chronized delivery of a vaccine of known effectiveness to all children, including probable suscep-
tible individuals, across a wide geographical area – was appropriate and epidemiologically sound. 
For a communicable disease such as poliomyelitis, in which most of  the infections are subclinical, 
where the transmission of the agent was widespread but resulted in relatively few cases (with oc-
casional major epidemics), it was probably the most effective, the most reliable and the most cost-
efficient way of interrupting endemic transmission and finally removing the threat of continuing 
disease.
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Contribution of individual countries and areas
To be successful, Operation MECACAR had to ensure the enthusiastic participation of all the 
individual countries and areas in an initiative that, while clearly to each country’s benefit, also 
involved a collective responsibility for controlling the disease over a wide geographical area. Not 
only did the original MECACAR countries and areas fully and enthusiastically cooperate together 
over a number of years, but, as transmission occured outside Operation MECACAR’s limits, 
other neighbouring countries later joined the initiative in implementing appropriate strategies. 
This resulted in countries and areas covering a vast geographical area, comprising most of the Eu-
ropean Region and a major part of the Eastern Mediterranean Region, collectively instituting the 
WHO recommended strategies for poliomyelitis eradication in coordination. The evident impact 
on the disease over most of this vast area is a testimony to the achievement.
Technically, the success of Operation MECACAR depended on reaching virtually all children in 
the target age group with supplementary doses of vaccine during a very short period of time 
in the low season of poliovirus transmission. This was successfully achieved through the NIDs, 
(with virtually all countries and areas involved reaching over 90% of their target group, usually 
over 95%) and in mopping-up. In order to achieve this it was necessary to plan for a number 
of key factors. These included a very strong commitment from the various ministries of health 
and from national immunization programme managers and other staff exercising a high level of 
technical, motivational and managerial skills.
Within countries and areas, success in achieving social mobilization, intersectoral cooperation, 
and the coordinated involvement of leading figures and personalities often depended on the 
strong involvement of leaders at the highest national level. The extension of responsibilities from 
ministries of health to other governmental sectors, nongovernmental organizations and to the 
community was a key factor in the success of Operation MECACAR. The commitment of na-
tional leaders, clearly demonstrated as they opened campaigns by immunizing the first children, 
with full media coverage, was of considerable importance.
Conducting NIDs, and continuing them for many years, involved a commitment of time, person-
nel and finance that placed additional burdens on frequently stretched national budgets. That no 
country had to renege on its promises is not only a credit to the commitment of ministries of 
health, but also reflects the outstanding efforts made to raise additional funding at the national, 
provincial, district and community levels.
Coordination among all parties concerned
The capacity and support in assisting health ministries to organize NIDs also reflects the strong 
coordination taking place within countries/areas among government, international agencies, na-
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tional NGOs and representatives of all levels of society. Without this enhanced cooperation and 
development of partnerships, it is doubtful whether the success would have been so comprehen-
sive. Equally, on the international level, the role of the WHO Regional Offices and their staff, both 
administrative and technical, plus the contributions from UNICEF and Rotary International and 
other external partners, were absolutely critical for success and cannot be underestimated.
On the technical level, it is essential to stress the critical role of the coordination meetings in 
which all countries/areas and agencies were fully and appropriately represented. This forum had 
a critical role in planning and coordinating activities, reviewing progress, sharing experiences 
and in discussing further technical developments beyond the limited scope of the NIDs. Without 
them and their effective conduct, Operation MECACAR could not have functioned so well.
Extension of Operation MECACAR beyond coordinated NIDs
An important element was also that the technical aspects of Operation MECACAR were extended 
beyond the originally planned NIDs to include development of effective AFP surveillance, and 
accreditation and use of the poliomyelitis virological laboratory network. Most importantly, the 
introduction and implementation of the concept of performance monitoring and evaluation and 
the use of standard performance indicators has provided a quantification of the progress and will, 
eventually, make it possible to certify the elimination of poliomyelitis from the two WHO regions, 
and thus contribute to the ultimate certification of global poliomyelitis eradication.
LASTING BENEFITS OF OPERATION MECACAR
The four lasting outcomes of Operation MECACAR are:
• the fact that poliomyelitis will have been eliminated when, otherwise, it either would not have 
been or would have taken far longer, with many unnecessarily disabled children;
• the development of a much strengthened capacity for labortory-based, standardized 
surveillance and consequent communicable disease control;
• the demonstrable willingness of non-health sectors and communities to be involved in health 
and humanitarian programmes; and
• the  demonstration that international cooperation in infectious disease control is not only 
possible and effective, but is clearly and enthusiastically welcomed by the Member States of 
each region.
THE FUTURE OF OPERATION MECACAR
Although strikingly successful to date, Operation MECACAR has not yet quite completed all 
its objectives. When the original three years of Operation MECACAR had been completed, it 
was clear that additional activities needed to be continued and accelerated, under Operation 
MECACAR Plus. Discussion at all the most recent coordination meetings stressed the need for 
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continuing well-coordinated activities into the future until certification of global eradication of 
poliomyelitis. As we enter 2001, fewer MECACAR countries and areas are now conducting full 
NIDs, and some MECACAR countries in the European Region will no longer need to conduct 
any supplementary immunization. Because the risk of cross-border importation of wild poliovi-
ruses will remain, coordinated Operation MECACAR Plus supplementary immunization activi-
ties will continue in key countries and areas at least up to and including 2003, even if AFP surveil-
lance should meet all necessary performance indicators and routine immunization services reach 
consistent and sustainable high coverage. 
The risk of unrecognized cross-border poliovirus transmission persists in two main areas: the 
Islamic Republic of Iran, Iraq, Turkey and the Syrian Arab Republic, and, more likely, in Afghani-
stan, the Islamic Republic of Iran, Pakistan, Tajikistan, Turkmenistan and Uzbekistan. Continu-
ing virus circulation in Afghanistan and Pakistan represents the major source for distant impor-
tations in both WHO regions, although importations from the continuing reservoirs in India and 
areas of Africa could also occur. Future MECACAR activities must build on the successes already 
achieved and extend them to ensure complete success.
Continuation of Operation MECACAR Plus means:
• continued coordinated supplementary immunization campaigns, where indicated (see Table 7 
for proposed activities in 2001–2003);
• coordinated action to improve AFP surveillance, with particular focus on high-risk areas;
• continued coordination among recently endemic countries and areas in order to achieve 
global certification of poliomyelitis eradication by the year 2005; and
• sharing of successful activities towards laboratory containment of wild poliovirus and 
potentially infectious materials.
In addition, laboratory support and specimen transportation will be further strengthened to  en-
sure that all countries and areas and their constituent districts have easy and expedited access to 
WHO-accredited laboratories.
A MECACAR coordination meeting is now planned for March 2001 in Cairo. With the successes 
achieved in Operation MECACAR and future actions towards poliomyelitis eradication now 
clear, discussion among MECACAR participants and partners in 2001 could also begin to include 
other communicable disease control and elimination programmes of shared interest as opportu-
nity for continued intercountry and interregional collaboration, including the shared target of 
regional elimination of measles.
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Melik Minas, last 
polio victim in the 
European Region 
in Agri province, 
Turkey 1998
PERSONAL RECOLLECTIONS ABOUT SOME PERSONS BEHIND 
OPERATION MECACAR
By Doctors Rafi Aslanian, Nedret Emiroglu, Hamid Jafari, George Oblapenko, M.H. Wahdan
The success of Operation MECACAR was due to the planning, the active support of national 
health authorities, the partnership of international and national organizations… and the hard, 
hard work and motivation of the operational field staff. The people behind the various aspects 
of the programme made the Operation what it was and is. 
July 1994
Early in the morning, during a WHO polio eradication planning session in Atlanta, two of us 
(George and Rafi) were preparing for the final discussion about future activities and we were ex-
cited about the previous day’s presentation by Dr Nicolas Ward on organizing national efforts 
around World Health Day 1995. And so, as we were discussing our own options, we placed on the 
table a dream to join efforts in the endemic countries of the two WHO regions that share a long 
border and shared plenty of wild polioviruses. 
January 1995
At the first coordination meeting in Ankara, all countries agreed to participate in the Operation 
but only two months remained to prepare field operations. In addition, there was a funding short-
fall of 5 million US dollars. Rotary International managed (practically overnight!) to transfer that 
amount to UNICEF/New York after which Mr Hyuk Soo Kwon and other UNICEF staff in Co-
penhagen worked hard to ensure that vaccine would be delivered in time, calculating every single 
cubic centimeter of available cargo space. 
EPILOGUE
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April 1995
I visited Kazakhstan to conduct an evaluation of the first round of NIDs. During evaluation, the 
team visited one district close to the border with China and met a local ophthalmologist riding 
a horse carrying OPV vaccine on the way. He was returning after the immunization session in a 
small hamlet. When we asked him about his experience, he responded, “I feel great! I have just im-
munized 17 children in that very remote place. You know, today 18 countries started an operation 
to eradicate poliomyelitis. I am very proud to be a part of that.” 
March 1997
We left Tehran, Islamic Republic of Iran early in the day to make sure we arrived in the western 
border province of Kurdestan not too late after sunset. The WHO regional offices and involved 
countries had just begun to focus attention on the poliovirus reservoir that involved the area bor-
dering northwestern Iran, northeastern Syria, northern Iraq and southeastern Turkey. We split 
into two teams on the following day, one covering provinces of the south and the other traveling 
north. 
Iran was the only country in the Region at that point that had conducted NIDs during which 
every single household in the country was visited. The impact of these massive undertakings was 
immense, but we were still not in a position to know with certainty whether Iran had interrupted 
indigenous virus transmission, even with the available laboratory data. Even if it had been inter-
rupted, similar viruses to what was in Iran in years past were circulating in Iraq and Turkey to the 
west and Pakistan and Afghanistan to the east. 
As we drove, we were talking among ourselves about the uniqueness of the Iranian public health 
system with the vice chancellors of medical universities being responsible for disease surveillance. 
The public health system in Iran was well decentralized but two public health veterans in the 
country were coordinating the polio eradication program centrally in Tehran. One of them, Dr 
Parviz Vazirian who was the overall coordinator of immunization and surveillance activities for 
polio eradication, was accompanying us. With good humor we kept challenging him during the 
drive about the weaknesses we could find in the field. In return, Dr Vazirian recited famous cou-
plets of Hafiz, the 13th century mystical poet from Shiraz, a demonstration of the confidence he 
had in his program.
Next day we drove to Qasr-e-Shirin near the Iraqi border. This province was the seat of Khusro 
Pervaiz the famous king of ancient Iran. The mythical love story of his queen Shirin, and her lover 
Farhad (who dug a mountain canal with only a pick axe to win her love) was played out thousands 
of years ago in what is now the town of Kermanshah. We were struck by the number of nomadic 
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tribes and families that were on the move in this rugged terrain. It was our hosts’ turn to challenge 
us now by asking us if we could find any unimmunized children among the nomads. Remarkably 
indeed, all the nomadic families we stopped to interview had vaccination cards and their children 
were immunized. As we learned later, even the 60-day follow up of AFP cases among nomads 
was completed through proper tracking of these mobile groups. Dr Vazirian recited some more 
Hafiz.
September 1997
On my first visit to Afghanistan, several WHO consultants and I had driven from Islamabad via 
Peshawar the day before to participate in a workshop on surveillance. We had crossed the border 
through the famous Khyber Pass where a large plaque informed the visitors of the historical sig-
nificance of this pass. This was the main passageway for the numerous philosophers, writers, po-
ets, sufis, preachers, kings and conquerors from central Asia who made their way to the Indian 
sub-continent and heavily influenced its culture, history and traditions during the previous mil-
lennium. Decades of armed conflict in Afghanistan were immediately apparent as we rattled in 
the land cruiser that jumped along the shell-pocked road to Jalalabad. Following a few multianti-
gen mass campaigns, Afghanistan had conducted its first polio NID early in 1997 but was the only 
MECACAR country that had no AFP surveillance. We knew from recent evaluations of patients 
obtaining services from rehabilitation clinics that, in addition to injuries from land mines, polio-
myelitis remained a major cause of disability in Afghanistan. 
What unfolded during the three days of the workshop was nothing short of a major programme 
transforming exercise. We were remarkably impressed by the capacity of the national staff to ab-
sorb complex technical information and use it to devise a brilliant operational plan for surveil-
lance based on case detection and reporting through active surveillance visits to selected “sentinel 
sites” in the capital cities of each of the regions. The stool specimens were to be flown on United 
Nations’ flights out of Afghanistan to the regional reference laboratory in Islamabad, Pakistan. In 
subsequent phases, surveillance would move down to provincial and district levels. The system 
started with 37 sentinel sites and by end of 2000 has expanded to nearly 200 reporting sites in 
more than 110 districts. Many of the major reporting sites are now also reporting measles and 
neonatal tetanus cases. The AFP surveillance system in Afghanistan turned out to be the template 
that was used to establish surveillance systems in many other conflict-affected areas of the world. 
E P I L O G U E
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August 1998
Closer to its source, the water of the Euphrates is a deeper shade of green in the Syrian Arab 
Republic compared with the colour seen in Iraq. Syria had already conducted several house-to-
house mopping up campaigns in high-risk border districts and towns near Iraq and Turkey. I was 
struck by the absence of city slums in Syria and noted markings left by immunization teams on 
houses during house-to-house campaigns. It was impossible to find unvaccinated children. Dr 
Osama and I spent two full days visiting urban and rural districts of Aleppo governorate review-
ing AFP cases, surveillance data, and campaign planning. 
Next day we drove to the district of Ain-al Arab and visited the cleanest and most impeccably 
organized district health center I have ever seen. The director of the local district health was a 
physician who had trained in Austria and settled in Vienna, then decided to return to his village of 
origin. He insisted and took us home for lunch. He lived on the edge of town, in fact on the edge 
of Syria, since it was from his front yard that I could see the houses in the province of Sanli Urfa, 
inside Turkey, where in the preceding months a number of virus-confirmed polio cases had been 
identified.
September 1998 
Dr Niama Abid Said from Ministry of Health, Iraq and I discussed the recently identified and 
ongoing outbreak of diphtheria in the Nineva governorate. After dinner we visited the shrine of 
the prophet Jonas on top of the hill in the town of Mosul. Later in the evening we decided to create 
a computerized line-list in the candlelight based on the information on diphtheria cases in pos-
session of Dr Said. Analysis revealed that the outbreak seemed to have started in an ethnic minor-
ity group that resisted vaccination and the center of the outbreak was located in the district of Sin-
jar. Armed conflict of considerable intensity was ongoing in the three northern governorates of 
Iraq. We met various public health staff and UNICEF colleagues in Erbil and Dohuk and learned 
about the extreme challenges polio eradication faced in this part of the world. Upon return to 
Baghdad, the mission team prepared a report with a long list of recommendations. Most remark-
ably, the authorities in Iraq rose up to the challenge and successfully implemented each and every 
recommendation towards a highly sensitive AFP surveillance system and a functioning national 
laboratory. It was this surveillance system that led to the identification of the last polio outbreak 
in mid-1999. The first identified cases of the outbreak also appeared in Sinjar district in the same 
ethnic minority. The authorities and the health workers in Iraq again rose up to the challenge 
of the outbreak and conducted high-quality house-to-house immunization campaigns that have 
led to the apparent interruption of virus transmission in Iraq.
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October 1998
From the beginning of the polio eradication programme in Turkey, the polio cases occurred pre-
dominantly in certain ethnic groups in the southeast and east. Sanli Urfa is a large province in 
that area of Turkey, which historically had accounted for a large proportion of the polio cases in 
Turkey in the many years before. With the NIDs since 1995, it was clear that a large number of 
parents were actively avoiding vaccination of their children. During the mopping-up campaign 
underway, district health workers reported that the parents in one of the remote villages of Halfeti 
district particularly were avoiding vaccination of the male children, even if allowing vaccination 
of the females, thinking that it could sterilize the males. In fact, the cases of polio seen in that year 
included an unvaccinated 18-month-old boy from Mus whose three sisters had received vaccine 
in the NIDs while he was hidden from the vaccinators by his grandmother, just months before 
becoming paralyzed. Dr Necip Yemenici from the provincial health office decided to take mat-
ters into his own hands. He had been impressed by the global polio eradication effort and took 
the message to heart that “We cannot afford to have a single child missed”. He took his team 
back to the village and met with the village head. As they together started to go house-to-house, 
he realized that he would need to do something extra to convince parents of OPV safety. As a 
newly married man, he told the parents at the first house that if it were not safe, would he take it? 
– and proceeded to give OPV drops to himself. Seeing that this broke the reserve, he then went on 
to demonstrate the safety by vaccinating his team members. This maneuver worked, so he went 
house-to-house, at each opening a fresh vial of vaccine to demonstrate for each reluctant parent 
how safe OPV was – and taking in almost 100 doses himself that day. His example was related 
throughout the province, and mopping-up monitoring that autumn indicated extremely high 
coverage. In addition to the high degree of planning and supervision to make the mopping-up 
succeed, the reluctance of some of the population was reduced. 
Because there are thousands and thousands of persons who worked to make Operation 
MECACAR succeed, there are thousands of stories to tell. As this hard work serves as an example 
for the rest of the world to follow, global polio eradication will be realized. The health of children 
in MECACAR countries will continue to be enhanced as this strong coalition works to further 
strengthen both AFP/virological surveillance and routine immunization programmes. 
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Across eleven time 
zones, also this 
child in Moscow 
joined the NIDs, 
Russian
Federation 1998
Clinical expert in 
poliomyelitis ex-
amines a child





“For me you come too late,” whispered Mihail in his wheelchair when I approached him 
during the opening ceremony of the NIDs in Chisinau, Republic of Moldova in September 
1996. The 12-year-boy was one of the three dozen children packed into the main hall of 
the polyclinic along with parents, grandparents and guests. He had brought his younger 
brother to be vaccinated “so he will not experience the same fate”. His words still sound in 
my ears and I vowed I would never have to hear them again.
Rotary International started its collaboration with the WHO Regional Office for Europe in 1993, 
after its successful intervention in the Americas. A Central and Eastern European Countries 
 PolioPlus Project Committee, later called European Regional PolioPlus Committee, was formed: 
• to support the vaccine supply in central and eastern Europe, Caucasus and central Asia;
• to exert advocacy, motivating Governments to persist in strengthening immunization and 
support of activities of social mobilization;
• to motivate the governments of the developed countries and the European Union, NGOs and 
relief agencies to cooperate in this endeavour by providing financial and material resources 
for vaccine supply, laboratory implementation and improvement, and a variety of equipment; 
and
• to obtain the personal commitment of Rotarians in helping to set up efficient laboratory-based 
surveillance systems in all countries and areas fighting for the eradication of polio. With over 
300,000 Rotarians in the European Region, including the former communist states, Rotary was 
in the best position to mobilize its members for the polio campaign.
A central point in the cooperation with the Regional Office was the 1994 partners meeting in 
Kyoto. Here the Interagency Immunization Coordination Committee was established, for which 
Rotary provided the chairmanship, and which became the large coalition of governments, in-
ternational agencies and NGOs that developed Operation MECACAR. MECACAR was the first 
multinational coordinated effort of its kind which successfully engaged 18 countries and areas 
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across two different WHO regions to immunize their children simultaneously. Rotary’s primary 
roles within the coalition have been the provision of polio vaccines, the promotion of vaccine self-
sufficiency in polio-endemic countries, the mobilization of volunteers to help in immunization 
campaigns, the coordination of efforts among coalition partners, advocacy efforts on behalf of 
polio eradication and support to the laboratory network, surveillance and social mobilization.
In addition to the commitment of financial support to MECACAR, Rotary took an experimental 
approach to NIDs with the Ministry of Health in Bulgaria, where social mobilization was carried 
out to ensure that all children were included in the immunization campaigns. Similar support 
activities took place in  the Republic of Moldova, Romania,  the Russian Federation, Ukraine and 
the Federal Republic of Yugoslavia. A successful approach to the Roma minority communities 
of Bulgaria and Romania brought many previously reluctant parents forward to vaccinate their 
children for the first time. The problem of those minorities either neglected or not using govern-
ment services presented a unique opportunity for Rotary to intervene. With its neutral position, 
removed from any political influence and partiality, Rotary had the legitimacy to convince the 
Kosovo Albanian leadership to accept vaccination of their children by the Serb health authorities, 
the Roma community to overcome prejudices, and the ethnic minorities in Bulgaria, Romania 
and elsewhere to benefit from NIDs under the umbrella of MECACAR.
During the years of Operation MECACAR, the European Region was confronted with many chal-
lenges. One of them was the large outbreak of poliomyelitis in Albania in May to November 1996. 
Fortunately, with the support of Rotary and other sources, two rounds of NIDs had already been 
conducted for children from 2 months to 5 years of age in the spring 1996, thus sparing this age 
group from polio disease; incidence rates of illness during the outbreak were therefore highest 
among persons 10 years and older. With broad international assistance, two rounds of mass vac-
cination for outbreak control were conducted, bringing the epidemic to a halt. A more difficult 
problem was Kosovo, where border circulation and low population immunity favoured the trans-
mission of the virus. In a crash operation coordinated by WHO, Rotary supported the vaccina-
tion of all children of the 6 to 16 age group in all schools in addition to the already planned sub-
NIDs for younger children in Kosovo. As a result of special efforts, two more rounds of sub-NIDs 
were again implemented each year in 1997-1998.
In addition to continuing the supply of vaccine to the other members of Operation MECACAR, 
Rotary’s efforts concentrated on Turkey in 1997, and the elimination of the last remaining chains 
of poliovirus transmission through door-to-door vaccinations in the high-risk regions. This re-
sulted in a raised level of immunity in the whole population, including the common ethnic mi-
norities in the wild poliovirus reservoirs of northern Iraq, southeastern Turkey, and northern 
Syrian Arab Republic. The financial commitment of Rotary and others in the coalition and the 
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involvement of local Rotarians in social mobilization and surveillance was crucial for the success 
of the operations and for achieving the apparent polio-free status of Turkey today.
Substantial efforts were also undertaken to strengthen the network of laboratories in both WHO 
regions and to improve the quality of AFP surveillance for the reliable detection of wild poliovirus 
transmission. The PolioPlus Partner Programme of The Rotary Foundation has provided consid-
erable assistance to the laboratory network and to surveillance and investigation activities, both 
of which are needed to achieve the necessary standards of virological surveillance for certifica-
tion. Laboratory equipment, computers and software, other office equipment and supplies, and 
specimen cold-chain carrier and collection kits to the total value of more than US$ 1 million were 
provided to the European Region. Rotary was moved by the conviction that the development and 
use of the WHO-accredited laboratory network is of paramount importance not only for the 
reporting system of surveillance but also for sharing epidemiological information among agen-
cies and countries long after the eradication of polio is completed. Accordingly, Rotary provided 
key support for the European Polio Laboratory Coordinator and advocacy to encourage other 
national governments to upgrade their laboratories as a part of the global polio network.
Rotarians in all European countries where Rotary exists have proven themselves well suited to 
handle some of the vital promotional and logistical steps, from increasing the demand for im-
munization to securing vaccine, transporting it and seeing that it is safely administered. Rotar-
ians worldwide supported local Rotarians in their social mobilization activities, generating com-
munity support for polio eradication. Using a variety of promotional means, Rotary clubs helped 
to inform the public about the critical need for polio immunization. By supplying vehicles and 
vaccine carriers, they ensured that vaccine arrived safely and on time at immunization sites.
Polio eradication is too big a job for any single organization to do alone. Operation MECACAR 
is a prime example of the results that can be achieved through the cooperation of governments, 
government agencies, and private organizations with the international agencies of the United Na-
tions. WHO’s strong leadership and technical guidance in this important coalition was crucial in 
successfully meeting the challenges of  polio eradication in pockets and entire areas at high risk, 
and in halting the transmission of the virus across borders. UNICEF’s ability to procure vaccine of 
high quality at low cost and deliver it in a timely fashion, as well as its social mobilization activities 
ensured that oral polio vaccine was available when needed and administered. Only through this 
common effort was it possible to deal with and solve all the problems.
Rotarians are undertaking advocacy for polio eradication with new fervour through a special 
Task Force. This high-level advocacy and fundraising activity is accomplished through the efforts 
of its network spanning all levels of government and private enterprise. In this way, Rotary alerted 
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the authorities of European countries and the European Union to the financial shortage of the 
various campaigns. Together they contributed over US$ 50 million to the global effort. 
The benefits from learning how to work cooperatively will have many future rewards in addition 
to the eradication of polio. Interagency cooperation can be effective in many other public health 
interventions. Relationships among the private sector, governments and intergovernmental agen-
cies are much stronger and specific roles for each group are now being determined in other pro-
grammes. The contribution made by public health workers to the success of a programme has 
also been recognized, ensuring continued acknowledgement of their role in the future. 
The cooperation within the MECACAR coalition was very rewarding. While the US$ 20 million 
contribution by Rotary to the European Region was critical in galvanizing global efforts to eradi-
cate polio, the most important contribution of our organization was that of human resource: lo-
cal Rotarian volunteers at the forefront of immunization activities guided by the proclamation 
of Past President Rotary International Cliff Dochterman that “the greatest happiness is helping 
others”.
Dr Mario Grassi
Former Chairman of the European Regional PolioPlus Committee
Massagno, Switzerland 
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Rotary’s PolioPlus Committees in Jordan, Lebanon and Pakistan have played key roles in advo-
cacy, social mobilization and implementation in the polio eradication efforts in these MECACAR 
countries of the Eastern Mediterranean Region of WHO. The advocacy efforts of National Polio-
Plus Committees and individual Rotarians led to stronger political commitment and the mobili-
zation of support from both the public and private institutions within these countries, 
as well as the mobilization of external resources to support OPV and operational costs 
for NIDs and sub-NIDs, surveillance enhancement and laboratory capacity building. An im-
portant direct contribution of Rotarians in these countries was their active involvement in 
social mobilization activities and in preparation and implementation of immunization cam-
paigns, including manpower for monitoring and assessment of the quality of the campaigns.
Through the support of Rotary’s International PolioPlus Committee and the PolioPlus Commit-
tee for the Eastern Mediterranean Region, the PolioPlus Committee of Pakistan has been the cor-
nerstone of support to the polio eradication programme there. Rotary International provided a 
grant to establish the AFP surveillance system nationwide in 1996 as a result of the involvement of 
the National Committee in partnership with WHO. Since those early days of the programme, 
the international support from the Rotary Foundation and PolioPlus Partners has continued to 
flow. The active participation of local Rotarians and the efforts of the National PolioPlus Com-
mittee have been recognized at the highest national forums. The Chairman of the Committee is 
being decorated with a civilian service award by the President of the Republic of Pakistan. The ad-
vocacy efforts of the Committee have resulted in Pakistan being one of the few countries that have 
printed a postage stamp on polio eradication – with the Rotary emblem. The Committee has also 
been involved in cross-border immunization activities, the planning and monitoring of NIDs in 
Afghanistan as a part of the WHO team, as well as in participating in inter-regional activities of 
WHO and UNICEF for bordering countries of the WHO regions for the Eastern Mediterranean 
and South-East Asia. The Committee gratefully acknowledges and appreciates the valuable part-
nership with WHO, UNICEF and CDC through MECACAR in strengthening the role and efforts 
of Rotary International and trusts that this support will continue until we reach our cherished 
goal of offering a polio-free world to our children.
Mr Abdul Haiy Khan
Chairman, PolioPlus Committee of Pakistan
Islamabad, Pakistan
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UNITED NATIONS CHILDREN’S FUND
Since 1995, Operation MECACAR has been a highly effective forum of interregional and inter-
country coordination of poliomyelitis eradication activities and the development of a coalition 
of partners, leading towards the halt of the transmission of wild poliovirus in the European and 
Eastern Mediterranean regions. 
UNICEF offices in the countries and areas of both regions have been ac-
tively involved in the planning and implementation of all activities carried 
out through this operation. National coordination produced a better quality 
planning and implementation of accelerated activities, with an emphasis on 
the so-called “unreached children” – children who had not benefited from 
polio vaccine in the past and who, for one reason or another, had also not received other basic 
health services. As a result of these activities, pockets of such children affected by the lack of serv-
ices have been identified and necessary services provided.
All activities carried out through Operation MECACAR have been planned and implemented as 
an integral part of the national immunization programmes, providing a positive synergetic effect 
on each other. The experience gained during this Operation is a valuable asset for future regional 
and intercountry cooperation in the area of disease control and elimination of such diseases as 
diphtheria, measles, tuberculosis, malaria and hepatitis B. Indeed, this experience has already 
been utilized in some of the current programmes. 
Regular, effective coordination meetings and reviews held during Operation MECACAR greatly 
influenced the programme direction and allocation of resources, and enhanced partners’ under-
standing of different countries’ priorities and needs.
Dr Alexander Malyavin
Project Officer for Health
UNICEF Regional Office for Central and Eastern Europe, 
Commonwealth of Independent States and Baltic States
Geneva, Switzerland 
Dr Ahmed Mohamed Magan
Project Officer for Health
UNICEF Middle East and North African Regional Office
Amman, Jordan
93P A R T N E R  S T A T E M E N T S
CENTERS FOR DISEASE CONTROL AND PREVENTION 
The groundwork for Operation MECACAR began in 1994, when the idea was suggested to build 
upon the few NIDs that had been conducted up to that time in some of the countries and areas 
of the WHO European and Eastern Mediterranean regions to create a solidly coordinated 
effort to interrupt poliovirus transmission across major portions of the European and 
Asian continents. The key elements of this groundwork were the  planning of its scope 
and objectives, obtaining the cooperation of all national authorities and international 
partners, and coordinating its timing and execution. All these elements came together be-
cause of the vision, persistence and professionalism of the founding fathers of Operation 
MECACAR, Drs George Oblapenko and Rafi Aslanian, of the respective two WHO regions. The 
continuing partnership that we call MECACAR continues to be a model for the other partner-
ships of CDC in the global poliomyelitis eradication initiative – effective partnerships being ab-
solutely necessary in order to reach the eradication goal – with the following shared concepts:
Opportunity: the opportunity to participate in programme development and implementation. 
The beauty of a partnership such as MECACAR is that it offers the opportunity for multilateral 
rather than just bilateral interactions and cooperation, which enriches the quality of the work and 
the results.
Team work: this concept has at least two components -
a) sharing responsibility for achieving programme objectives among country public health 
workers (from district to central levels), volunteers, laboratory workers, bilateral agencies and 
international organizations; and
b) drawing on the particular strengths that each international organization brings to the 
partnership, for example:
• WHO:  technical skills, mobilization of political commitment, leadership
• Rotary:  advocacy, community mobilization, mobilization of political commitment at the 
 county level, funding support
• UNICEF:  country level programme management and implementation
• CDC:  technical skills, funding support.
Interdependence: the concept that each country is dependent on the quality of work of its neigh-
bouring countries/areas, and each region upon adjoining regions, since the poliovirus knows no 
boundaries. This idea brings forth the need for all countries/areas and organizations to help each 
other, for only in this way will all benefit.
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Enhanced communication and coordination: in this way, the partnership can avoid duplication 
of effort, and increase efficient and effective use of resources. It is like a team of horses that can 
pull together in a single direction when the pathway is established.
Accomplishment: a network of highly proficient, accredited laboratories with a truly global ex-
tent has been created, and immunization delivery and surveillance aspects of public health pro-
grammes have been strengthened, along with the meeting of the primary objectives. 
Expansion of collective knowledge gained and lessons learned: poliomyelitis eradication, and 
the experience we have all had with MECACAR, can be a model for the future. Poliomyelitis 
eradication is the model for building close linkages between modern laboratory science and pub-
lic health implementation on a global scale. The challenge before us is to translate and extend 
all these lessons in cooperation learned from Operation MECACAR into cooperation in other 
areas.
CDC takes this opportunity to thank the countries and areas of the Eastern Mediterranean and 
European regions, WHO, Rotary International, UNICEF, USAID and all the other partners for 
the opportunity to participate in, contribute to and learn from this historic MECACAR partner-
ship.
Dr Steve Cochi
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Operation MECACAR/ MECACAR Plus provided countries and areas of the WHO European 
and Eastern Mediterranean regions with a forum for information sharing, consensus building 
and problem solving regarding polio eradication and immunization-related issues. By engaging 
a wide range of partner organizations and interested parties in the coordination meetings and 
other planning, USAID believes countries/areas will benefit from a broader resource base as well 
as having a broader base to share and exchange ideas about programme performance. Interna-
tional partners enhance their understanding of national resource needs when there are regular 
reviews of budgets, financial implications and human resource needs in a manner that is trans-
parent and where countries/areas are accountable for funds as well as results. 
Given that communicable diseases respect no borders, Operation MECACAR is in an excellent 
position to expand its objectives; such cooperation provides a politically neutral venue for dis-
cussing problems, challenges and concerns about the spread and control of other selected infec-
tious diseases. The actions needed to control these diseases can be agreed upon and coordinated 
under the MECACAR umbrella. With the dual purposes of reporting back and using data for ac-
tion, MECACAR has the potential, with continued strong leadership, to be an innovative mecha-
nism not only for meeting technical objectives but also for advocacy, motivation of health work-
ers, and recognizing achievements. By continuing thorough discussion at coordination meetings, 
programmatic shortcomings can be addressed – professionally, but directly – and authorities en-
couraged to take appropriate corrective action after a peer-review process provides consensus 
recommendations. 
Brought together by common needs, countries/areas can help each other to find appropriate, 
cost-effective solutions to problems that affect us all. Ultimately, MECACAR could help save 
more lives, reduce costs, and improve the performance of a broad range of immunization and 
disease control activities in countries and areas under its umbrella.
Ms Ellyn Ogden
Worldwide Polio Eradication Coordinator
Dr Murray Trostle
Senior Immunization Advisor
U.S. Agency for International Development
Washington D.C., USA
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